{"content":"<li class=\"n-box-item date-title\" data-end=\"1520053199\" data-start=\"1519966800\" data-txt=\"Monday, December 23, 2019\">Friday, March  2, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3336235\" data-ts=\"1520030175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEON\" target=\"_blank\">VEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336235-after-hours-gainers-losers-3-2-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (3/2/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/ORBC' title='ORBCOMM Inc.'>ORBC</a> <font color='green'>+1.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/QEP' title='QEP Resources, Inc.'>QEP</a> <font color='red'>-5.0%</font>. <a href='https://seekingalpha.com/symbol/FLEX' title='Flex Ltd..'>FLEX</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a> <font color='red'>-3.7%</font>. <a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a> <font color='red'>-3.5%</font>. <a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a> <font color='red'>-3.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336235\" data-linked=\"After Hours Gainers / Losers (3/2/2018)\" data-tweet=\"$VEON $VEON $CASA - After Hours Gainers / Losers (3/2/2018) https://seekingalpha.com/news/3336235-after-hours-gainers-losers-3-2-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336235-after-hours-gainers-losers-3-2-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336234\" data-ts=\"1520030020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYMT\" target=\"_blank\">NYMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336234-nymt-fnsr-gnl-on-move-amid-index-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYMT, FNSR, GNL on move amid index changes</a></h4><ul>   <li>New York Mortgage Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/NYMT' title='New York Mortgage Trust, Inc.'>NYMT</a>) is <font color='green'>up 3.7%</font> after hours on word that it's <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/671577_ipgalenymtgnl5466.pdf?force_download=true\" target=\"_blank\">moving into the S&amp;P SmallCap 600</a>.</li>    <li>It's replacing Allete (NYSE:<a href='https://seekingalpha.com/symbol/ALE' title='ALLETE, Inc.'>ALE</a>), which is heading up to the MidCap 400 to replace IPG Photonics (<a href='https://seekingalpha.com/symbol/IPGP' title='IPG Photonics Corporation'>IPGP</a>, <font color='green'>up 0.2%</font> after hours), which itself is moving into the S&amp;P 500 to take over for Scripps Networks Interactive (NYSE:<a href='https://seekingalpha.com/symbol/SNI' title='Scripps Networks Interactive, Inc.'>SNI</a>).</li>    <li>Scripps Networks is set to be acquired by Discovery Communications around Tuesday; those moves are effective before Wednesday's open.</li>    <li>Meanwhile, Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>) is <font color='green'>up 4.4%</font> postmarket on its move into the SmallCap 600, where it will replace LendingTree (NASDAQ:<a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a>) -- which itself is headed to the MidCap 400 to replace Bioverativ (NASDAQ:<a href='https://seekingalpha.com/symbol/BIVV' title='Bioverativ Inc.'>BIVV</a>), set to be acquired by Sanofi next week. Those moves are effective prior to Thursday's open.</li>    <li>And Global Net Lease (NYSE:<a href='https://seekingalpha.com/symbol/GNL' title='Global Net Lease, Inc.'>GNL</a>) is <font color='green'>up 2.8%</font> postmarket as it's headed to the SmallCap 600 to replace GCI Liberty (GNCMA), set to close its acquisition by Liberty Interactive/Liberty Ventures. The move is effective before the open next Friday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336234\" data-linked=\"NYMT, FNSR, GNL on move amid index changes\" data-tweet=\"$NYMT $NYMT $ALE - NYMT, FNSR, GNL on move amid index changes https://seekingalpha.com/news/3336234-nymt-fnsr-gnl-on-move-amid-index-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/3336234-nymt-fnsr-gnl-on-move-amid-index-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336224\" data-ts=\"1520027551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336224-weekly-etf-gainers-losers-3-2-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers (3/2/18)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='green'>+11.3%</font>. <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='green'>+1.6%</font>. <a href='https://seekingalpha.com/symbol/DBA' title='PowerShares DB Agriculture ETF'>DBA</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/FXY' title='Guggenheim CurrencyShares Japanese Yen Trust ETF'>FXY</a> <font color='green'>+1.1%</font>. <a href='https://seekingalpha.com/symbol/PGF' title='PowerShares Financial Preferred Portfolio ETF'>PGF</a> <font color='green'>+0.7%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/KOL' title='VanEck Vectors Coal ETF'>KOL</a> <font color='red'>-5.6%</font>. <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a> <font color='red'>-5.2%</font>. <a href='https://seekingalpha.com/symbol/FXI' title='iShares China Large-Cap ETF'>FXI</a> <font color='red'>-4.9%</font>. <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/AMJ' title='JPMorgan Alerian MLP Index ETN'>AMJ</a> <font color='red'>-4.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336224\" data-linked=\"Weekly ETF Gainers / Losers (3/2/18)\" data-tweet=\"$VXX $UNG $DBA - Weekly ETF Gainers / Losers (3/2/18) https://seekingalpha.com/news/3336224-weekly-etf-gainers-losers-3-2-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3336224-weekly-etf-gainers-losers-3-2-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336213\" data-ts=\"1520025445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSD\" target=\"_blank\">CLSD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336213-clearside-bio-to-announce-phase-3-data-on-cls-ta-premarket-monday-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clearside Bio to announce Phase 3 data on CLS-TA premarket Monday; shares up 2% after hours</a></h4><ul><li>Clearside Biomedical (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a>) will release <a href=\"https://seekingalpha.com/pr/17090964-clearside-biomedical-schedules-conference-call-review-topline-results-pivotal-phase-3\" target=\"_blank\">top-line results</a> from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02595398?titles=peachtree&amp;spons=clearside+biomedical&amp;phase=2&amp;rank=1\" target=\"_blank\">PEACHTREE </a>study assessing suprachoroidal CLS-TA (triamcinolone acetonide) in patients with macular edema associated with non-infectious uveitis.</li><li>The primary endpoint was the proportion of patients achieving at least a 15-letter improvement in a scale called ETDRS BCVA at visit 8 (24 weeks) compared to sham injection (placebo).</li><li>Management will host a conference call Monday morning at 8:30 am ET to discuss the data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336213\" data-linked=\"Clearside Bio to announce Phase 3 data on CLS-TA premarket Monday; shares up 2% after hours\" data-tweet=\"$CLSD - Clearside Bio to announce Phase 3 data on CLS-TA premarket Monday; shares up 2% after hours https://seekingalpha.com/news/3336213-clearside-bio-to-announce-phase-3-data-on-cls-ta-premarket-monday-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3336213-clearside-bio-to-announce-phase-3-data-on-cls-ta-premarket-monday-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336212\" data-ts=\"1520025416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336212-ford-says-trump-tariffs-harm-competitiveness-of-american-manufacturers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford says Trump tariffs could harm &quot;competitiveness of American manufacturers&quot;</a></h4><ul><li>        Ford Motor Co. (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) <a href=\"https://www.reuters.com/article/usa-trade-ford-motor/ford-motor-co-warns-trump-metal-tariffs-may-hike-commodity-prices-idUSL2N1QK1MN?feedType=RSS&amp;feedName=companyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FcompanyNews+%28News+%2F+US+%2F+Company+News%29\" target=\"_blank\">says</a> President Trump&rsquo;s steel and aluminum tariffs could significantly drag earnings this year.</li><li>               Ford does note that the company buys &ldquo;the vast majority of its steel and aluminum for U.S. production in the U.S.&rdquo; but says that the tariffs could harm the &ldquo;competitiveness of American manufacturers.&rdquo;&nbsp;</li><li>               Ford shares closed today&nbsp;<font color='green'>up 1.3%</font>&nbsp;to $10.40.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335997-trumps-tariffs-deal-another-blow-already-slowing-u-s-auto-sales\" target=\"_blank\">Trump's tariffs could deal another blow to already slowing U.S. auto sales</a> (March 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336212\" data-linked=\"Ford says Trump tariffs could harm &quot;competitiveness of American manufacturers&quot;\" data-tweet=\"$F - Ford says Trump tariffs could harm &quot;competitiveness of American manufacturers&quot; https://seekingalpha.com/news/3336212-ford-says-trump-tariffs-harm-competitiveness-of-american-manufacturers?source=tweet\" data-url=\"https://seekingalpha.com/news/3336212-ford-says-trump-tariffs-harm-competitiveness-of-american-manufacturers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336211\" data-ts=\"1520025280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336211-netflix-rallies-to-top-300-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix rallies to top $300/share</a></h4><ul>   <li>With a final-hour push, Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) shares crossed the $300 barrier to tab an all-time high of $301.18.</li>    <li>It had gotten closer earlier in the week before a couple of flat days of trading.</li>    <li>The move capped a <font color='green'>3.7% gain</font> on the day that pushed the company's market cap to $130.6B.</li>    <li>Shares had actually closed down slightly yesterday after the company <a href=\"https://seekingalpha.com/news/3335632-netflix-inks-deal-sky\" target=\"_blank\">signed a deal</a> with the UK's Sky to join its pay bundle.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3334240-netflix-300-watch\" target=\"_blank\">The Netflix $300 watch is on</a> (Feb. 26 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336211\" data-linked=\"Netflix rallies to top $300/share\" data-tweet=\"$NFLX - Netflix rallies to top $300/share https://seekingalpha.com/news/3336211-netflix-rallies-to-top-300-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3336211-netflix-rallies-to-top-300-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>181&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336203\" data-ts=\"1520024215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IHRTQ\" target=\"_blank\">IHRTQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336203-malone-and-liberty-buying-debt-iheartmedia-bankruptcy-imminent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Malone and Liberty buying debt with iHeartMedia bankruptcy imminent</a></h4><ul>   <li>With iHeartMedia (<a href=\"http://seekingalpha.com/symbol/IHRT\" target=\"_blank\">IHRT</a> <font color='green'>+5.8%</font>) headed toward a bankruptcy filing as soon as the weekend, GSO Capital Partners is exiting a key role in the restructuring by <a href=\"https://www.bloomberg.com/news/articles/2018-03-02/gso-said-to-exit-iheart-after-selling-debt-to-malone-s-liberty\" target=\"_blank\">selling its position</a> to John Malone and Liberty Media (<a href=\"http://seekingalpha.com/symbol/FWONA\" target=\"_blank\">FWONA</a> <font color='green'>+2.9%</font>).</li>    <li>GSO sold about $400M in debt to Liberty Media, Bloomberg reports, in an attempt by Malone to step to the forefront of the reorg and take control of the company's radio business.</li>    <li>Malone and Liberty had <a href=\"https://seekingalpha.com/news/3334406-liberty-media-steps-1_16b-offer-40-percent-struggling-iheart\" target=\"_blank\">stepped up earlier with a $1.16B offer</a> to take 40% of a post-bankruptcy iHeart in conjunction with Sirius XM (<a href=\"http://seekingalpha.com/symbol/SIRI\" target=\"_blank\">SIRI</a> <font color='red'>-0.3%</font>), a deal that's still under negotiation.</li>    <li>GSO, the credit unit of Blackstone Group (<a href=\"http://seekingalpha.com/symbol/BX\" target=\"_blank\">BX</a> <font color='red'>-0.5%</font>), has been a leading force in negotiations with iHeart that have extended well over a year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336203\" data-linked=\"Malone and Liberty buying debt with iHeartMedia bankruptcy imminent\" data-tweet=\"$IHRTQ $IHRT $FWONA - Malone and Liberty buying debt with iHeartMedia bankruptcy imminent https://seekingalpha.com/news/3336203-malone-and-liberty-buying-debt-iheartmedia-bankruptcy-imminent?source=tweet\" data-url=\"https://seekingalpha.com/news/3336203-malone-and-liberty-buying-debt-iheartmedia-bankruptcy-imminent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336198\" data-ts=\"1520023708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWN\" target=\"_blank\">SWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336198-southwestern-energyplus-19-on-strong-q4-record-exit-rate-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southwestern Energy +19% on strong Q4, record exit-rate production</a></h4><ul>     <li>Southwestern Energy (<a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color='green'>+19%</font>) surges after reporting a solid <a href=\"https://seekingalpha.com/news/3335885-southwestern-energy-beats-0_03-beats-revenue\" target=\"_blank\">Q4 earnings</a> beat and an 18% Y/Y revenue increase, plus record exit-rate production from the Appalachian Basin.</li>     <li>SWN says FY 2017 total net production was 897B cfe, including 578B cfe from the Appalachian Basin with record gross operated 2017 exit rate production of 2.35B cfe/day, a 40% increase vs. year-end 2016.</li>     <li>Year-end total proved reserves reached a record 14.8T cfe (75% natural gas and 25% natural gas liquids and condensate), including 11.1T cfe from the Appalachian Basin, up a respective 181% and 393% Y/Y.</li>     <li>Net cash provided by operating activities in FY 2017 totaled $1.1B, up 120% Y/Y, and net cash flow was $1.14B, up 76% Y/Y.</li>     <li>SWN says its focus in 2018 will be on exploring strategic alternatives for its Fayetteville shale assets while accelerating development in Appalachia.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336198\" data-linked=\"Southwestern Energy +19% on strong Q4, record exit-rate production\" data-tweet=\"$SWN - Southwestern Energy +19% on strong Q4, record exit-rate production https://seekingalpha.com/news/3336198-southwestern-energyplus-19-on-strong-q4-record-exit-rate-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3336198-southwestern-energyplus-19-on-strong-q4-record-exit-rate-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336170\" data-ts=\"1520023355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFH\" target=\"_blank\">AFH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336170-atlas-financial-shares-down-41-on-increase-in-loss-reserves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlas Financial shares down 41% on increase in loss reserves</a></h4><ul><li>The company announced it needs to strengthen the reserves after an internal audit and actuarial assessment.</li><li>Caim expenses in Michigan and other businesses are seem settling for greater amounts than previously expected.</li><li><a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings'>AFH</a> shares are&nbsp;<font color='red'>down 41.5%&nbsp;</font></li><li>Source: <a href=\"https://seekingalpha.com/pr/17089989-atlas-financial-holdings-announces-preliminary-2017-fourth-quarter-year-end-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3336170\" data-linked=\"Atlas Financial shares down 41% on increase in loss reserves\" data-tweet=\"$AFH - Atlas Financial shares down 41% on increase in loss reserves https://seekingalpha.com/news/3336170-atlas-financial-shares-down-41-on-increase-in-loss-reserves?source=tweet\" data-url=\"https://seekingalpha.com/news/3336170-atlas-financial-shares-down-41-on-increase-in-loss-reserves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336195\" data-ts=\"1520022609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNT\" target=\"_blank\">INNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336195-innovate-bio-up-55-news-scarce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Innovate Bio up 55% but news scarce</a></h4><ul><li>Thinly traded nano cap Innovate Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='green'>+54.5%</font>) is up on a whopping 46x surge in volume. No particular news accounts for the action.</li><li>It recently completed a <a href=\"https://www.sec.gov/Archives/edgar/data/1551986/000114420418010607/tv486960_8k.htm\" target=\"_blank\">reverse recapitalization</a> with Monster Digital (MSDI). At the end of Q3 2017, the company had <a href=\"https://www.sec.gov/Archives/edgar/data/1551986/000114420417057296/tv478679_10q.htm#a_001\" target=\"_blank\">$174K in cash</a> and operations consumed an average of ~$1M during the first three quarters of 2017 so it has an acute need for capital.</li><li>Its lead product candidate is Phase 3-stage <a href=\"http://www.innovatebiopharma.com/inn-202.html\" target=\"_blank\">larazotide </a>(INN-202) for the treatment of celiac disease.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336195\" data-linked=\"Innovate Bio up 55% but news scarce\" data-tweet=\"$INNT - Innovate Bio up 55% but news scarce https://seekingalpha.com/news/3336195-innovate-bio-up-55-news-scarce?source=tweet\" data-url=\"https://seekingalpha.com/news/3336195-innovate-bio-up-55-news-scarce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336194\" data-ts=\"1520021992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEG\" target=\"_blank\">PEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336194-public-service-exelon-cancel-capital-spending-salem-nuclear-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Public Service, Exelon cancel capital spending at Salem nuclear plant</a></h4><ul>     <li>Public Service Enterprise Group (<a href='https://seekingalpha.com/symbol/PEG' title='Public Service Enterprise Group Inc.'>PEG</a> <font color='red'>-2%</font>) and Exelon (<a href='https://seekingalpha.com/symbol/EXC' title='Exelon Corporation'>EXC</a> <font color='red'>-0.7%</font>) say they will <a href=\"https://finance.yahoo.com/m/bb2fce8b-4143-3dd7-a3e5-906b76264e66/ss_pseg-canceling-nuclear-plant.html\" target=\"_blank\">cancel funding of future capital projects</a> at the Salem nuclear plant, after a $300M taxpayer-funded financial bailout of New Jersey's nuclear industry stalled in the state legislature.</li>     <li>PSEG says the decision comes after \"recent postponements\" of a vote on legislation, but funding for the projects could be restored if legislation is enacted \"that sufficiently values the attributes of nuclear generation and Salem benefits from such legislation.\"</li>     <li>New Jersey generates ~40% of its electricity from nuclear power, and PSEG says its plants, including the Salem facility and Hope Creek, are in danger of becoming financially unsustainable within two years, which led the company to ask lawmakers for financial help from ratepayers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336194\" data-linked=\"Public Service, Exelon cancel capital spending at Salem nuclear plant\" data-tweet=\"$PEG $PEG $EXC - Public Service, Exelon cancel capital spending at Salem nuclear plant https://seekingalpha.com/news/3336194-public-service-exelon-cancel-capital-spending-salem-nuclear-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3336194-public-service-exelon-cancel-capital-spending-salem-nuclear-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336191\" data-ts=\"1520020790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGNA\" target=\"_blank\">TGNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336191-tegnaplus-3_7-after-earnings-wells-fargo-lifts-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tegna +3.7% after earnings; Wells Fargo lifts estimates</a></h4><ul>   <li>Tegna (NYSE:<a href='https://seekingalpha.com/symbol/TGNA' title='TEGNA'>TGNA</a>) is <font color='green'>up 3.7%</font> after profits <a href=\"https://seekingalpha.com/news/3335563-tegna-beats-0_02\" target=\"_blank\">beat expectations</a> last evening, and Wells Fargo has raised its 2018 profit estimates.</li>    <li>The company's finally benefiting from streaming bundles, analyst Marci Ryvicker says, lifting the firm's estimate for 2018 EPS to $1.63 (from $1.46), and setting a 2019 EPS target of $1.43. (h/t Bloomberg)</li>    <li>Ryvicker has an Outperform rating and a price target of $19, implying 41% upside from today's higher price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336191\" data-linked=\"Tegna +3.7% after earnings; Wells Fargo lifts estimates\" data-tweet=\"$TGNA - Tegna +3.7% after earnings; Wells Fargo lifts estimates https://seekingalpha.com/news/3336191-tegnaplus-3_7-after-earnings-wells-fargo-lifts-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3336191-tegnaplus-3_7-after-earnings-wells-fargo-lifts-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336190\" data-ts=\"1520020502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336190-technology-top-gainers-losers-of-2_55-pm-3-01-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (3/01/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/TRHC' title='Tabula Rasa HealthCare'>TRHC</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336190\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (3/01/18)\" data-tweet=\"$AMBA $AMBA $RUBI - Technology - Top Gainers / Losers as of 2.55 pm (3/01/18) https://seekingalpha.com/news/3336190-technology-top-gainers-losers-of-2_55-pm-3-01-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3336190-technology-top-gainers-losers-of-2_55-pm-3-01-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336189\" data-ts=\"1520020336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336189-caterpillar-deere-headline-industrial-sector-ratings-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caterpillar, Deere headline industrial sector ratings at Morgan Stanley</a></h4><ul>     <li>Caterpillar (<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='red'>-2%</font>) is the <a href=\"https://thefly.com/thestreet/realmoney/index.php/CATid2693166/CAT-Caterpillar-initiated-with-an-Overweight-at-Morgan-Stanley\" target=\"_blank\">favorite stock in the construction machinery space</a> for Morgan Stanley's Courtney Yakavonis, who thinks shares have more room to run amid an ongoing recovery in the global economy and growth in key end markets such as energy, mining, and North American infrastructure.</li>     <li>Deere (<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='red'>-1.9%</font>) is the analyst's <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11295722/morgan-stanley-overweight-on-wabco-deere-caterpillar-un\" target=\"_blank\">top pick in agriculture machinery</a> due to its outsized exposure to the North American replacement cycle and a potential rebound in corn and soybean prices; the firm rates both stocks at Outperform with respective $185 and $195 price targets.</li>     <li>United Rentals (<a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a> <font color='green'>+1.5%</font>) is seen surging in North American equipment rentals, and Yakavonis rates shares at Overweight with a $194 target price.</li>     <li>In trucking, Overweight-rated Wabco (<a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a> <font color='red'>-1%</font>) enjoys <a href=\"https://www.barrons.com/articles/machinery-stocks-can-keep-trucking-1520005008\" target=\"_blank\">stable European exposure</a> and tailwinds from safety regulations but Paccar (<a href='https://seekingalpha.com/symbol/PCAR' title='PACCAR Inc.'>PCAR</a> <font color='red'>-2.6%</font>) is Underweight due to its exposure to the heavy-duty truck market, which has been falling off.</li><li>Rated Equal Weight: <a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a>, <a href='https://seekingalpha.com/symbol/REVG' title='REV Group'>REVG</a>, <a href='https://seekingalpha.com/symbol/CNHI' title='CNH Industrial N.V.'>CNHI</a>, <a href='https://seekingalpha.com/symbol/AGCO' title='AGCO Corporation'>AGCO</a>, <a href='https://seekingalpha.com/symbol/OSK' title='Oshkosh Corporation'>OSK</a>, <a href='https://seekingalpha.com/symbol/TEX' title='Terex Corporation'>TEX</a></li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/XLI' title='Industrial Select Sector SPDR ETF'>XLI</a>, <a href='https://seekingalpha.com/symbol/VIS' title='Vanguard Industrials ETF'>VIS</a>, <a href='https://seekingalpha.com/symbol/FIDU' title='Fidelity MSCI Industrials Index ETF'>FIDU</a>, <a href='https://seekingalpha.com/symbol/IFLY' title='PureFunds Drone Economy Strategy ETF'>IFLY</a>, <a href='https://seekingalpha.com/symbol/IYJ' title='iShares U.S. Industrials ETF'>IYJ</a>, <a href='https://seekingalpha.com/symbol/FXR' title='First Trust Industrials AlphaDEX ETF'>FXR</a>, <a href='https://seekingalpha.com/symbol/AIRR' title='First Trust RBA American Industrial Renaissance ETF'>AIRR</a>, <a href='https://seekingalpha.com/symbol/RGI' title='Invesco S&P Equal Weight Industrial ETF'>RGI</a>, <a href='https://seekingalpha.com/symbol/UXI' title='ProShares Ultra Industrials ETF'>UXI</a>, <a href='https://seekingalpha.com/symbol/SIJ' title='ProShares UltraShort Industrials ETF'>SIJ</a>, <a href='https://seekingalpha.com/symbol/JHMI' title='John Hancock Multifactor Industrials ETF'>JHMI</a>, <a href='https://seekingalpha.com/symbol/INDF' title='iShares Edge MSCI Multifactor Industrials ETF'>INDF</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3336189\" data-linked=\"Caterpillar, Deere headline industrial sector ratings at Morgan Stanley\" data-tweet=\"$CAT $CAT $DE - Caterpillar, Deere headline industrial sector ratings at Morgan Stanley https://seekingalpha.com/news/3336189-caterpillar-deere-headline-industrial-sector-ratings-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3336189-caterpillar-deere-headline-industrial-sector-ratings-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336186\" data-ts=\"1520018818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALK\" target=\"_blank\">ALK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336186-airlines-cancel-nearly-2_6k-us-flights-due-to-storms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airlines cancel nearly 2.6K US flights due to storms</a></h4><ul><li>        Airlines <a href=\"https://www.usatoday.com/story/travel/flights/todayinthesky/2018/03/02/airlines-cancel-1-600-flights-noreaster-snarls-travel/388080002/\" target=\"_blank\">cancel nearly 2,600 flights</a> due to the nor&rsquo;easter in the Mid-Atlantic and Northeast of the US.</li><li>               Nationwide, 2,587 flights were canceled and 1,447 delayed as of 12:45 PM ET, according to FlightAware.&nbsp;</li><li>               Most airlines are waiving change fees for today and tomorrow for flights going to or from the affected airports.&nbsp;</li><li>               Airline stocks that could move on the news: Alaska Air Group (<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a> <font color='red'>-2.2%</font>), American Airlines (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color='red'>-0.7%</font>), Delta (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='red'>-0.4%</font>), JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color='green'>+0.8%</font>), Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='red'>-0.2%</font>), and Spirit Airlines (<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a> <font color='green'>+3.6%</font>).&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336150-delta-announces-february-operating-results\" target=\"_blank\">Delta announces February operating results</a> (March 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336157-delta-ceo-we-taking-sides-guns\" target=\"_blank\">Delta CEO: 'We are not taking sides' on guns</a> (March 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336186\" data-linked=\"Airlines cancel nearly 2.6K US flights due to storms\" data-tweet=\"$ALK $ALK $AAL - Airlines cancel nearly 2.6K US flights due to storms https://seekingalpha.com/news/3336186-airlines-cancel-nearly-2_6k-us-flights-due-to-storms?source=tweet\" data-url=\"https://seekingalpha.com/news/3336186-airlines-cancel-nearly-2_6k-us-flights-due-to-storms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336185\" data-ts=\"1520018686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336185-healthcare-leads-big-rebound\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare leads big rebound</a></h4><ul><li>A panicky start to the session has reversed big-time, with the Nasdaq now&nbsp;<font color='green'>up 0.5%</font>&nbsp;and the S&amp;P 500&nbsp;<font color='green'>0.1%</font>. The Dow is just modestly lower.</li><li>Leading the way today is the healthcare sector (<a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a> <font color='green'>+0.6%</font>), in particular the biotechs (<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='green'>+2%</font>).</li><li>Among the movers: JNJ&nbsp;<font color='green'>+1%</font>, Merck&nbsp;<font color='green'>+1%</font>, Celgene&nbsp;<font color='green'>+2.3%</font>, Incyte&nbsp;<font color='green'>+3.3%</font>, Biogen&nbsp;<font color='green'>+1.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336185\" data-linked=\"Healthcare leads big rebound\" data-tweet=\"$XLV $IBB - Healthcare leads big rebound https://seekingalpha.com/news/3336185-healthcare-leads-big-rebound?source=tweet\" data-url=\"https://seekingalpha.com/news/3336185-healthcare-leads-big-rebound\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336184\" data-ts=\"1520018460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336184-bloomberg-no-company-risk-from-trade-retaliation-boeing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: No company more at risk from trade retaliation than Boeing</a></h4><ul>     <li>Pres. Trump's tariff action and CEO Dennis Muilenburg's cozy relationship with the president has set Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-1.3%</font>) <a href=\"https://www.bloomberg.com/gadfly/articles/2018-03-02/trump-s-just-set-boeing-on-a-collision-course-with-china\" target=\"_blank\">on a collision course with China</a>, according to Bloomberg columnist David Fickling.</li>     <li>There's the obvious risk of increased costs - ~80% of an aircraft's weight is aluminum - but Boeing's 3.5% drop yesterday after Trump announced his tariff plans \"should be a warning sign that, beyond the current clear skies, a storm is building,\" Fickling writes.</li>     <li>Of the&nbsp;10 U.S. businesses with more than $5B of sales in China, three (Apple, Las Vegas Sands and Procter &amp; Gamble) are dependent on consumer spending, and six are in the semiconductor and tech businesses that China wants to encourage domestically, so they should be somewhat safe from government action - \"Against that backdrop, Boeing stands out like a sore thumb.\"</li>     <li>\"Should the current tit-for-tat over steel and aluminum spiral toward a trade war,&nbsp;few firms will find themselves in a more precarious position than Boeing,\" Fickling concludes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336184\" data-linked=\"Bloomberg: No company more at risk from trade retaliation than Boeing\" data-tweet=\"$BA - Bloomberg: No company more at risk from trade retaliation than Boeing https://seekingalpha.com/news/3336184-bloomberg-no-company-risk-from-trade-retaliation-boeing?source=tweet\" data-url=\"https://seekingalpha.com/news/3336184-bloomberg-no-company-risk-from-trade-retaliation-boeing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>124&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336183\" data-ts=\"1520017920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LTBR\" target=\"_blank\">LTBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336183-energy-materials-top-gainers-losers-of-2-10-pm-3-1-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:10 pm (3/1/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ZEUS' title='Olympic Steel, Inc.'>ZEUS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336183\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:10 pm (3/1/2018)\" data-tweet=\"$LTBR $LTBR $SWN - Energy/Materials - Top Gainers / Losers as of 2:10 pm (3/1/2018) https://seekingalpha.com/news/3336183-energy-materials-top-gainers-losers-of-2-10-pm-3-1-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336183-energy-materials-top-gainers-losers-of-2-10-pm-3-1-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336179\" data-ts=\"1520016629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336179-amazon-web-services-networking-issue-impacts-alexa-cloud-clients\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon Web Services networking issue impacts Alexa, cloud clients</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) Web Services <a href=\"https://www.cnbc.com/2018/03/02/amazon-cloud-networking-outage-affecting-atlassian-twilio-slack.html?__source=twitter%7Cmain\" target=\"_blank\">acknowledges</a> a networking issue in data centers in Virginia.</li><li>               Amazon mentioned the issue at around 10:30 AM ET and issued an update about an hour ago saying some connections remained inactive.&nbsp;</li><li>               Affected corporate customers include Atlassian (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a>), Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a>), and MongoDB (NASDAQ:<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a>). &nbsp;&nbsp;</li><li>               Amazon&rsquo;s Alexa voice assistant is also experiencing connection issues.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='green'>down 0.9%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336179\" data-linked=\"Amazon Web Services networking issue impacts Alexa, cloud clients\" data-tweet=\"$AMZN $AMZN $TEAM - Amazon Web Services networking issue impacts Alexa, cloud clients https://seekingalpha.com/news/3336179-amazon-web-services-networking-issue-impacts-alexa-cloud-clients?source=tweet\" data-url=\"https://seekingalpha.com/news/3336179-amazon-web-services-networking-issue-impacts-alexa-cloud-clients\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336177\" data-ts=\"1520016261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITCI\" target=\"_blank\">ITCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336177-sell-siders-bullish-on-intra-cellular-ahead-of-key-data-readouts-shares-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-siders bullish on Intra-Cellular ahead of key data readouts; shares up 15%</a></h4><ul><li>Intra-Cellular Therapies (<a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a> <font color='green'>+15.3%</font>) is up on 42% higher volume. The company reported Q4 results yesterday that underwhelmed investors, but buying has picked up today on renewed enthusiasm for its <a href=\"https://seekingalpha.com/pr/17088762-intra-cellular-therapies-reports-fourth-quarter-full-year-2017-financial-results-provides\" target=\"_blank\">pipeline</a>.</li><li>Cantor's William Tanner, SunTrust's Ed Nash and Cowen's Ritu Baral are all bullish on the company's prospects. Tanner and Baral have $28 (33% upside) price targets on the stock.</li><li>Lead candidate is <a href=\"http://www.intracellulartherapies.com/products-and-technology/lumateperone/\" target=\"_blank\">lumateperone</a>, Fast Track'd in the U.S. for schizophrenia. The company plans to meet with the agency this month ahead of an NDA filing mid-year. The serotonin, dopamine and glutamate modulator is also being developed for bipolar depression &#40;BD&#41;, dementia-related behavioral disturbances and neuropsychiatric disorder-associated sleep disturbances.</li><li>Top-line data from a U.S.-based Phase 3 BD study are expected in H2 followed by results from a global BD study in 2019. If all goes well, an NDA will be filed in the U.S. in H2 2019. Preliminary results from a Phase 3 in dementia-associated behavioral disturbances should be available in H2.</li><li>Candidate #2 is PDE inhibitor<a href=\"http://www.intracellulartherapies.com/products-and-technology/pde-inhibitor-platform/\" target=\"_blank\"> ITI-214</a>, in Phase 1/2 development for heart failure and Parkinson's disease &#40;PD&#41;. Top-line data from the PD study should be released in H2.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294106-intra-cellular-therapies-announces-positive-topline-data-safety-switching-study-lumateperone\" target=\"_blank\">Intra-Cellular Therapies announces positive topline data from safety switching study with Lumateperone in patients with Schizophrenia; shares ahead 20% premarket</a> (Sept. 7, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336177\" data-linked=\"Sell-siders bullish on Intra-Cellular ahead of key data readouts; shares up 15%\" data-tweet=\"$ITCI - Sell-siders bullish on Intra-Cellular ahead of key data readouts; shares up 15% https://seekingalpha.com/news/3336177-sell-siders-bullish-on-intra-cellular-ahead-of-key-data-readouts-shares-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3336177-sell-siders-bullish-on-intra-cellular-ahead-of-key-data-readouts-shares-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336174\" data-ts=\"1520014363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336174-jpmorgan-lowers-iphone-x-production-estimate-to-15m-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan lowers iPhone X production estimate to 15M in Q1</a></h4><ul><li>        JPMorgan reduces its production estimates for the Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhone X to as low as 15M in Q1, down from 20M.</li><li>                  Analyst Narci Chang also lowers Q2 estimates from 18M to 10M.    </li><li>               For all iPhones Chang lowers the Q1 forecast to 52M (was: 55M), Q2 to 42M (was: 45M), and full-year from 225M (+2% to 3%) versus the previous estimate of 9% growth.&nbsp;</li><li>               The firm upgrades Apple supplier Catcher Technology to Overweight from Neutral while cutting forecasts for Largan (<a href='https://seekingalpha.com/symbol/LGANF' title='Largan Precision Co., Ltd.'>OTC:LGANF</a>) to Neutral and AAC Technologies (<a href='https://seekingalpha.com/symbol/AACAF' title='AAC Technologies Holdings Inc'>OTCPK:AACAF</a>) to Overweight.&nbsp;</li><li>               Bloomberg First Word&nbsp;</li><li>               Apple shares are&nbsp;<font color='green'>up 0.4%</font>&nbsp;to $175.65.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3326489-deutsche-bank-apple-consensus-estimates-still-high-q1-q2\" target=\"_blank\">Deutsche Bank: Apple consensus estimates still too high for Q1, Q2</a> (Jan. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336174\" data-linked=\"JPMorgan lowers iPhone X production estimate to 15M in Q1\" data-tweet=\"$AAPL $AAPL $LGANF - JPMorgan lowers iPhone X production estimate to 15M in Q1 https://seekingalpha.com/news/3336174-jpmorgan-lowers-iphone-x-production-estimate-to-15m-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3336174-jpmorgan-lowers-iphone-x-production-estimate-to-15m-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336171\" data-ts=\"1520014141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZBH\" target=\"_blank\">ZBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336171-zimmer-biomet-mulling-sale-of-dental-unit-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zimmer Biomet mulling sale of dental unit - WSJ</a></h4><ul><li>The Wall Street Journal <a href=\"https://www.wsj.com/articles/zimmer-biomet-holdings-considering-sale-of-dental-unit-1519992000\" target=\"_blank\">reports </a>that Zimmer Biomet Holdings (<a href='https://seekingalpha.com/symbol/ZBH' title='Zimmer Biomet Holdings, Inc.'>ZBH</a> <font color='green'>+3.1%</font>) is considering divesting its dental business according to sources close to the matter. BofA Merrill Lynch is advising.</li><li>The unit generated EBITDA of $109M in 2017 on sales of almost $419M.</li><li><strong>Update</strong>: Gabelli &amp; Co. projects a valuation of up to $1.6B for the division.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336171\" data-linked=\"Zimmer Biomet mulling sale of dental unit - WSJ\" data-tweet=\"$ZBH - Zimmer Biomet mulling sale of dental unit - WSJ https://seekingalpha.com/news/3336171-zimmer-biomet-mulling-sale-of-dental-unit-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3336171-zimmer-biomet-mulling-sale-of-dental-unit-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336208\" data-ts=\"1520013458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATI\" target=\"_blank\">ATI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336208-allegheny-tech-raised-to-buy-bofa-merrill-keybanc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Tech raised to Buy at BofA Merrill, KeyBanc</a></h4><ul>     <li>Allegheny Technologies (<a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a> <font color='green'>+3.8%</font>) shoots higher after earning upgrades from both BofA Merrill Lynch and KeyBanc.</li><li>BAML <a href=\"https://thefly.com/thestreet/realmoney/index.php/ATIid2693157/ATI-Allegheny-Technologies-upgraded-to-Buy-at-BofAMerrill-on-valuation\" target=\"_blank\">boosts ATI to Buy</a> from Neutral with a $32 price target, saying the stock's recent weakness presents an attractive entry opportunity given the company's expected benefits from the jet engine new technology cycle.</li><li>The firm thinks the recent selloff may have been driven by concerns over the impact of  U.S. steel tariffs on its sourcing relationship with China's Tsingshan,  but ATI management has expressed  confidence in  receiving an exception to any slab tariff.</li><li>KeyBanc <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11296188/keybanc-comfort-around-flat-rolled-margins-valuation-le\" target=\"_blank\">upgrades</a> shares to Overweight from Sector Weight with a $31 price target, citing improved comfort in the margin improvement potential of the flat-rolled segment and noting its 2019 sum-of-the-parts valuation analysis yields an eventual share value above $35.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336208\" data-linked=\"Allegheny Tech raised to Buy at BofA Merrill, KeyBanc\" data-tweet=\"$ATI - Allegheny Tech raised to Buy at BofA Merrill, KeyBanc https://seekingalpha.com/news/3336208-allegheny-tech-raised-to-buy-bofa-merrill-keybanc?source=tweet\" data-url=\"https://seekingalpha.com/news/3336208-allegheny-tech-raised-to-buy-bofa-merrill-keybanc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336168\" data-ts=\"1520013087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNJN\" target=\"_blank\">FNJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336168-finjanplus-11_9-b-riley-weighs-positives-of-symantec-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finjan +11.9%; B. Riley weighs positives of Symantec settlement</a></h4><ul>   <li>Finjan Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a>) is <font color='green'>up 11.9%</font> today, following up on postmarket gains after the company <a href=\"https://seekingalpha.com/news/3335829-finjan-symantec-settle-disputes-finjan-plus-10_5-percent\" target=\"_blank\">struck an agreement settling disputes</a> with Symantec.</li>    <li>Considering the payments to Finjan involved, it should set up the company to exit the quarter with nearly $80M in cash and no offsetting preferred litigation financing -- and it means that the company should already be past a projected $40M in Q1 revenue, says B. Riley/FBR in an update note.</li>    <li>\"Additionally, FNJN now marches forward not only with a filled war chest and recent high water line for licensing\" but also a validity ruling in a Blue Coat case that should put other companies that are in license discussions on notice, says analyst Mike Crawford.</li>    <li>He has a $5 price target, implying 43% further upside beyond today's gains so far.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336168\" data-linked=\"Finjan +11.9%; B. Riley weighs positives of Symantec settlement\" data-tweet=\"$FNJN - Finjan +11.9%; B. Riley weighs positives of Symantec settlement https://seekingalpha.com/news/3336168-finjanplus-11_9-b-riley-weighs-positives-of-symantec-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3336168-finjanplus-11_9-b-riley-weighs-positives-of-symantec-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336167\" data-ts=\"1520013079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCP\" target=\"_blank\">QCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336167-financials-top-5-gainers-losers-of-12-50-pm-03-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 12:50 PM (03/02/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/QCP' title='Quality Care Properties, Inc.'>QCP</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/HLNE' title='Hamilton Lane Inc'>HLNE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/WHF' title='WhiteHorse Finance'>WHF</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings'>AFH</a> <font color='red'>-40%</font>. <a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336167\" data-linked=\"Financials - Top 5 Gainers / Losers as of 12:50 PM (03/02/2018)\" data-tweet=\"$QCP $QCP $HLNE - Financials - Top 5 Gainers / Losers as of 12:50 PM (03/02/2018) https://seekingalpha.com/news/3336167-financials-top-5-gainers-losers-of-12-50-pm-03-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336167-financials-top-5-gainers-losers-of-12-50-pm-03-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336165\" data-ts=\"1520012459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336165-midday-gainers-losers-3-2-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (3/2/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/VEC' title='Vectrus'>VEC</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/QCP' title='Quality Care Properties, Inc.'>QCP</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/APEI' title='American Public Education, Inc.'>APEI</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color='green'>+18%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings'>AFH</a> <font color='red'>-41%</font>. <a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/EGL' title='Engility Holdings'>EGL</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/RDUS' title='Radius Health, Inc.'>RDUS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336165\" data-linked=\"Midday Gainers / Losers (3/2/2018)\" data-tweet=\"$ZSAN $ZSAN $VEC - Midday Gainers / Losers (3/2/2018) https://seekingalpha.com/news/3336165-midday-gainers-losers-3-2-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336165-midday-gainers-losers-3-2-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336164\" data-ts=\"1520012448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336164-health-insurance-exchange-ehealth-under-pressure-on-soft-2017-revenue-and-accounting-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurance exchange eHealth under pressure on soft 2017 revenue and accounting change; shares down 9%</a></h4><ul><li>Thinly traded micro cap eHealth (<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color='red'>-8.5%</font>) is down on more than double normal volume, albeit on turnover of only ~370K shares, after it <a href=\"https://seekingalpha.com/pr/17090156-ehealth-inc-announces-fourth-quarter-fiscal-2017-results\" target=\"_blank\">announced </a>Q4 and 2017 results that included softer 2018 guidance from a change in accounting treatment for revenue recognition. Shares were down over&nbsp;<font color='red'>15%&nbsp;</font>before recovering.</li><li>2017 sales were $158.4M, down 7.3% yoy, shy of its <a href=\"https://seekingalpha.com/pr/16982024-ehealth-inc-announces-third-quarter-2017-results\" target=\"_blank\">previously announced</a> guidance of $165M - 175M.</li><li>On a preliminary basis, while it finalizes the impact of the accounting change, 2018 revenues are projected to be $186M - 191M. Confusingly, it then states that revenues this year will be $217.5M - 227.5M based on the adoption of the new revenue recognition standard. Consensus view is $239M so whichever range is accurate is still below current expectations.</li><li>Jefferies' David Styblo (HOLD/$18) says the accounting change created a \"large disconnect between P&amp;L and cash flow\" which artificially inflated the former. He adds that individual and family plan enrollment continues to shrink, down 38% yoy, and cash reserves may drop to $5M - 10M in Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336164\" data-linked=\"Health insurance exchange eHealth under pressure on soft 2017 revenue and accounting change; shares down 9%\" data-tweet=\"$EHTH - Health insurance exchange eHealth under pressure on soft 2017 revenue and accounting change; shares down 9% https://seekingalpha.com/news/3336164-health-insurance-exchange-ehealth-under-pressure-on-soft-2017-revenue-and-accounting-change?source=tweet\" data-url=\"https://seekingalpha.com/news/3336164-health-insurance-exchange-ehealth-under-pressure-on-soft-2017-revenue-and-accounting-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336161\" data-ts=\"1520010580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336161-big-bounce-for-stocks-brings-nasdaq-green\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big bounce for stocks brings Nasdaq into the green</a></h4><ul><li>The major averages were&nbsp;<font color='red'>lower by nearly 2%&nbsp;</font>at their worst levels this morning, but the dip-buyers have returned.</li><li>The S&amp;P 500 is now down only marginally on the session, and the Nasdaq is&nbsp;<font color='green'>up 0.2%</font>. Weighed by a&nbsp;<font color='red'>5% decline</font>&nbsp;in <a href=\"https://seekingalpha.com/news/3336086-mcdonalds-2_7-percent-dour-rbc-note\" target=\"_blank\">McDonald's</a>, the Dow is&nbsp;<font color='red'>off 0.8%</font>.</li><li>The 10-year Treasury yield is up a big five basis points to 2.87%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336161\" data-linked=\"Big bounce for stocks brings Nasdaq into the green\" data-tweet=\"Big bounce for stocks brings Nasdaq into the green https://seekingalpha.com/news/3336161-big-bounce-for-stocks-brings-nasdaq-green?source=tweet\" data-url=\"https://seekingalpha.com/news/3336161-big-bounce-for-stocks-brings-nasdaq-green\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336160\" data-ts=\"1520010362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTIC\" target=\"_blank\">OTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336160-fda-oks-otonomys-otiprio-for-acute-otitis-externa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Otonomy&#39;s Otiprio for acute otitis externa</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17090830-otonomy-announces-fda-approval-otiprio-r-acute-otitis-externa\" target=\"_blank\">approves </a>Otonomy's (<a href='https://seekingalpha.com/symbol/OTIC' title='Otonomy'>OTIC</a> <font color='red'>-0.9%</font>) OTIPRIO (ciprofloxacin otic suspension) 6% for the treatment of patients at least six months old with <a href=\"https://en.wikipedia.org/wiki/Otitis_externa\" target=\"_blank\">acute otitis externa</a> (infection of the ear canal) due to <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em>.</li><li>OTIPRIO is the first single-dose antibacterial approved in the U.S. for the infection.</li><li>Shares, currently halted, will resume trading at 12:15 pm ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3279138-fda-accepts-otonomys-marketing-application-otiprio-swimmers-ear-shares-1-percent-premarket\" target=\"_blank\">FDA accepts Otonomy's marketing application for OTIPRIO for swimmer's ear; shares up 1% premarket</a> (July 18, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336160\" data-linked=\"FDA OKs Otonomy&#39;s Otiprio for acute otitis externa\" data-tweet=\"$OTIC - FDA OKs Otonomy&#39;s Otiprio for acute otitis externa https://seekingalpha.com/news/3336160-fda-oks-otonomys-otiprio-for-acute-otitis-externa?source=tweet\" data-url=\"https://seekingalpha.com/news/3336160-fda-oks-otonomys-otiprio-for-acute-otitis-externa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336159\" data-ts=\"1520010332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRTV\" target=\"_blank\">VRTV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336159-consumer-top-gainers-losers-of-12-05-pm-3-2-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:05 pm (3/2/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VRTV' title='Veritiv'>VRTV</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SUMR' title='Summer Infant, Inc.'>SUMR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/MGPI' title='MGP Ingredients, Inc.'>MGPI</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336159\" data-linked=\"Consumer - Top Gainers / Losers as of 12:05 pm (3/2/2018)\" data-tweet=\"$VRTV $VRTV $KODK - Consumer - Top Gainers / Losers as of 12:05 pm (3/2/2018) https://seekingalpha.com/news/3336159-consumer-top-gainers-losers-of-12-05-pm-3-2-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336159-consumer-top-gainers-losers-of-12-05-pm-3-2-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336123\" data-ts=\"1520007545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336123-healthcare-top-5-gainers-losers-of-11-15-3-2-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:15 am (3/2/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AZRX' title='AzurRX Biopharma'>AZRX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/APEN' title='Apollo Endosurgery'>APEN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336123\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:15 am (3/2/2018)\" data-tweet=\"$ZSAN $ZSAN $AVGR - Healthcare - Top 5 Gainers / Losers as of 11:15 am (3/2/2018) https://seekingalpha.com/news/3336123-healthcare-top-5-gainers-losers-of-11-15-3-2-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336123-healthcare-top-5-gainers-losers-of-11-15-3-2-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336150\" data-ts=\"1520007130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336150-delta-announces-february-operating-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta announces February operating results</a></h4><ul><li>        Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) <a href=\"https://seekingalpha.com/pr/17090676-delta-reports-operating-performance-february-2018\" target=\"_blank\">announces</a> its operating performance for February with 13M passengers boarded, up 2.7% on the year.</li><li>               More results: Total System RPMs (000), 14.6M&nbsp; (+3.8% Y/Y); Total System ASMs (000), 18M (+3.4%); Total System Load Factor, 81.5% (+0.4 ppts); Mainline Completion Factor, 99.9% (+0.4 pts); Mainline On-time Performance, 87.8% (-1.7 pts); Cargo Ton Miles (000), 160K (+7.9%).&nbsp;</li><li>               Delta Air Lines shares are&nbsp;<font color='red'>down 1.6%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336013-georgia-lawmakers-nix-proposed-tax-break-delta-air-lines-nra-fight\" target=\"_blank\">Georgia lawmakers nix proposed tax break for Delta Air Lines in NRA fight</a> (March 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336150\" data-linked=\"Delta announces February operating results\" data-tweet=\"$DAL - Delta announces February operating results https://seekingalpha.com/news/3336150-delta-announces-february-operating-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3336150-delta-announces-february-operating-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336141\" data-ts=\"1520005414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PK\" target=\"_blank\">PK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336141-park-hotels-down-5-chinese-backer-looks-to-sell-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Park Hotels down 5% as Chinese backer looks to sell stake</a></h4><ul><li>Chinese conglomerate HNA Group has been looking to raise cash following $50B in acquisitions over the past couple of years. The next asset to go might be Park Hotels &amp; Resorts (<a href='https://seekingalpha.com/symbol/PK' title='Park Hotels & Resorts Inc.'>PK</a> <font color='red'>-4.7%</font>), with HNA indicating <a href=\"https://seekingalpha.com/filing/3915916\" target=\"_blank\">plans to sell at </a>least part of its 25% stake in the company.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335886-park-hotels-and-resorts-beats-0_07-beats-revenue\" target=\"_blank\">Park Hotels &amp; Resorts beats by $0.07, beats on revenue</a> (March 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336141\" data-linked=\"Park Hotels down 5% as Chinese backer looks to sell stake\" data-tweet=\"$PK - Park Hotels down 5% as Chinese backer looks to sell stake https://seekingalpha.com/news/3336141-park-hotels-down-5-chinese-backer-looks-to-sell-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3336141-park-hotels-down-5-chinese-backer-looks-to-sell-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336138\" data-ts=\"1520004699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336138-oppenheimer-trims-walmart-rating-on-e-commerce-growth-concern\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer trims Walmart rating on e-commerce growth concern</a></h4><ul>    <li>Oppenheimer has cut Walmart (<a href=\"http://seekingalpha.com/symbol/WMT\" target=\"_blank\">WMT</a> <font color='red'>-1.6%</font>) to Market Perform from Outperform as it frets the e-commerce slowdown tipped in the retail giant's <a href=\"https://seekingalpha.com/news/3332171-walmart-sets-full-year-profit-guidance-expectations\" target=\"_blank\">Q4 report</a>.</li>    <li>E-commerce sales rose 23% in Q4, and the firm says there's risk to a goal of 40% gains.</li>    <li>\"We are increasingly concerned that with recent key drivers of outsized e-commerce sales expansion potentially waning and given our now more muted EPS growth expectation, the <a href=\"https://www.marketwatch.com/story/walmart-downgraded-as-e-commerce-slowdown-tempers-earnings-growth-prospects-2018-03-02?siteid=yhoof2&amp;yptr=yahoo\" target=\"_blank\">valuation at which shares trade could prove capped</a>,\" Oppenheimer says, but points to positives including a stronger comp trajectory, improved financial discipline and an expanding omnichannel presence.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336138\" data-linked=\"Oppenheimer trims Walmart rating on e-commerce growth concern\" data-tweet=\"$WMT - Oppenheimer trims Walmart rating on e-commerce growth concern https://seekingalpha.com/news/3336138-oppenheimer-trims-walmart-rating-on-e-commerce-growth-concern?source=tweet\" data-url=\"https://seekingalpha.com/news/3336138-oppenheimer-trims-walmart-rating-on-e-commerce-growth-concern\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336137\" data-ts=\"1520004326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336137-rio-tintominus-3-on-concerns-over-canada-to-u-s-aluminum-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Tinto -3% on concerns over Canada-to-U.S. aluminum supply</a></h4><ul>     <li>Rio Tinto (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-3.1%</font>) is the <a href=\"https://www.ft.com/content/8ccd80e4-1dfc-11e8-aaca-4574d7dabfb6\" target=\"_blank\">biggest supplier of aluminum to the U.S.</a>, exporting ~1.4M metric tons/year from its smelters in Canada, so shares are sliding in reaction to Pres. Trump&rsquo;s planned 10% tariff on imports of the metal.</li>     <li>Rio&rsquo;s aluminum business racked up $1.6B in earnings in 2017, its best performance since the company's 2007 acquisition of Alcan,</li>     <li>Rio&rsquo;s total Canadian production is 1.9M metric tons/year, with 75% shipped to the U.S., and the company has been considering possible expansion of Canadian operations given improved market conditions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336137\" data-linked=\"Rio Tinto -3% on concerns over Canada-to-U.S. aluminum supply\" data-tweet=\"$RIO - Rio Tinto -3% on concerns over Canada-to-U.S. aluminum supply https://seekingalpha.com/news/3336137-rio-tintominus-3-on-concerns-over-canada-to-u-s-aluminum-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/3336137-rio-tintominus-3-on-concerns-over-canada-to-u-s-aluminum-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336135\" data-ts=\"1520003673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TM\" target=\"_blank\">TM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336135-toyota-launches-new-co-in-billion-dollar-autonomous-vehicle-push\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toyota launches new co. in billion-dollar autonomous vehicle push</a></h4><ul><li>        Toyota Motor Co. (NYSE:<a href='https://seekingalpha.com/symbol/TM' title='Toyota Motor Corporation'>TM</a>) tells suppliers it plans to spend billions to get autonomous cars to consumers, according to <a href=\"https://www.marketwatch.com/story/toyota-to-spend-3-billion-on-new-company-devoted-to-self-driving-cars-2018-03-02#false\" target=\"_blank\">WSJ.</a></li><li>               Toyota, Denso (<a href='https://seekingalpha.com/symbol/DNZOY' title='Denso Corp. ADR'>OTCPK:DNZOY</a>), and Aisin Seiki will create a new autonomous vehicle software company called Toyota Research Institute-Advanced Development and fund it with $2.8B over an undisclosed time frame. &nbsp;&nbsp;</li><li>               The Tokyo-based company will have around 300 employees at launch with the aim of more than tripling that number.&nbsp;</li><li>               Toyota set itself a 2020 deadline for selling autonomous cars that can work on freeways.&nbsp;</li><li>               Toyota Motor Corp. shares are&nbsp;<font color='red'>down 1%</font>&nbsp;still weighted from President Trump&rsquo;s tariff announcement yesterday.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335997-trumps-tariffs-deal-another-blow-already-slowing-u-s-auto-sales\" target=\"_blank\">Trump's tariffs could deal another blow to already slowing U.S. auto sales</a> (March 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336135\" data-linked=\"Toyota launches new co. in billion-dollar autonomous vehicle push\" data-tweet=\"$TM $TM $DNZOY - Toyota launches new co. in billion-dollar autonomous vehicle push https://seekingalpha.com/news/3336135-toyota-launches-new-co-in-billion-dollar-autonomous-vehicle-push?source=tweet\" data-url=\"https://seekingalpha.com/news/3336135-toyota-launches-new-co-in-billion-dollar-autonomous-vehicle-push\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336132\" data-ts=\"1520002976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336132-nxp-semiconductors-announces-senior-note-redemption\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NXP Semiconductors announces senior note redemption</a></h4><ul><li>        NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>) announces a planned redemption of 5.75% senior notes due 2023.</li><li>               The company will fully redeem the $500M of outstanding principle on April 2 funded with cash on the balance sheet.&nbsp;</li><li>               NXP shares are&nbsp;<font color='red'>down 0.2%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336132\" data-linked=\"NXP Semiconductors announces senior note redemption\" data-tweet=\"$NXPI - NXP Semiconductors announces senior note redemption https://seekingalpha.com/news/3336132-nxp-semiconductors-announces-senior-note-redemption?source=tweet\" data-url=\"https://seekingalpha.com/news/3336132-nxp-semiconductors-announces-senior-note-redemption\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336129\" data-ts=\"1520002659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336129-cheddar-snap-planning-second-third-versions-of-spectacles-glasses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheddar: Snap planning second, third versions of Spectacles glasses</a></h4><ul>    <li>Despite some disappointment over the uptake on Snap's (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color='green'>+1.7%</font>) camera-fitted Spectacles eyewear, the company is planning <a href=\"https://cheddar.com/videos/exclusive-snap-to-release-new-spectacles-this-year\" target=\"_blank\">more versions of the eyeglasses</a>, with a second version coming this fall, Cheddar reports.</li>    <li>That would be followed by a more ambitious third version with multiple cameras that could cost $300, more than double the current Spectacles cost.</li>    <li>The company lost $40M on the first Spectacles product, with hundreds of thousands of pairs unsold vs. about 150,000 moved.</li>    <li>The ambitious third version's two cameras would allow for 3D-like depth in video, and it might include such features as built-in GPS and a leather case, the report says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336129\" data-linked=\"Cheddar: Snap planning second, third versions of Spectacles glasses\" data-tweet=\"$SNAP - Cheddar: Snap planning second, third versions of Spectacles glasses https://seekingalpha.com/news/3336129-cheddar-snap-planning-second-third-versions-of-spectacles-glasses?source=tweet\" data-url=\"https://seekingalpha.com/news/3336129-cheddar-snap-planning-second-third-versions-of-spectacles-glasses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336128\" data-ts=\"1520002579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336128-microsoft-buying-output-from-singapore-clean-energy-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft buying output from Singapore clean energy project</a></h4><ul><li>        Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) <a href=\"https://www.cnbc.com/2018/03/02/microsoft-inks-its-first-clean-energy-deal-in-asia-with-solar-project.html\" target=\"_blank\">agrees to buy</a> the full energy output from a 60MW solar project from Singapore&rsquo;s Sunseap Group.</li><li>               The agreement between Microsoft and Sunseap will last 20 years and marks the tech giant&rsquo;s first clean energy deal in Asia.</li><li>               Microsoft says the project will involve solar panels across hundreds of roofs in the region.&nbsp;</li><li>               Late last year, Microsoft and GE entered into a 15-year wind energy agreement in Ireland.&nbsp;</li><li>               Microsoft shares are&nbsp;<font color='red'>down 1.5%</font>.&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299911-microsoft-ge-announce-15-year-wind-energy-deal-ireland\" target=\"_blank\">Microsoft, GE announce 15-year wind energy deal in Ireland</a> (Oct. 9, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336128\" data-linked=\"Microsoft buying output from Singapore clean energy project\" data-tweet=\"$MSFT - Microsoft buying output from Singapore clean energy project https://seekingalpha.com/news/3336128-microsoft-buying-output-from-singapore-clean-energy-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3336128-microsoft-buying-output-from-singapore-clean-energy-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336127\" data-ts=\"1520002263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRX\" target=\"_blank\">XRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336127-icahn-and-deason-continue-pressure-on-xerox-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Icahn and Deason continue pressure on Xerox board</a></h4><ul><li>\"We believe the Board has exhibited a clear pattern of failure,\" says Carl Icahn and Darwin Deason, <a href=\"http://carlicahn.com/joint-statement-with-darwin-deason-regarding-xerox-4/\" target=\"_blank\">in a letter</a> to Xerox (<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a> <font color='red'>-1.3%</font>) shareholders following Deason's request to re-open the window for board nominations.</li><li>\"We believe there is absolutely no reason Xerox shareholders should trust Fuji (<a href='https://seekingalpha.com/symbol/FUJIY' title='FUJIFILM Holdings Corp. ADR'>OTCPK:FUJIY</a>) ...&nbsp;Why would we ever accept being a minority shareholder in a company controlled by a competitor?\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3334416-deason-seeks-nominate-new-xerox-board\" target=\"_blank\">Deason seeks to nominate new Xerox board</a> (Feb. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336127\" data-linked=\"Icahn and Deason continue pressure on Xerox board\" data-tweet=\"$XRX $XRX $FUJIY - Icahn and Deason continue pressure on Xerox board https://seekingalpha.com/news/3336127-icahn-and-deason-continue-pressure-on-xerox-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3336127-icahn-and-deason-continue-pressure-on-xerox-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336126\" data-ts=\"1520002092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSTO\" target=\"_blank\">VSTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336126-vista-outdoorminus-9-co-ops-halt-brand-sales-over-gun-stance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vista Outdoor -9% as co-ops halt brand sales over gun stance</a></h4><ul>   <li>REI is <a href=\"https://www.washingtonpost.com/news/morning-mix/wp/2018/03/02/gun-boycott-rei-mountain-equipment-co-op-stop-selling-major-outdoor-brand-due-to-its-weapons-sales-nra-ties/?utm_term=.606089523f17\" target=\"_blank\">halting orders of Vista Outdoor</a> (<a href=\"http://seekingalpha.com/symbol/VSTO\" target=\"_blank\">VSTO</a> <font color='red'>-9%</font>) brands -- including well-known names like CamelBak water bottles and Bell bicycle helmets -- after the outdoor retailer notes a lack of a statement from NRA-tied Vista on the Florida school shooting, <i>The Washington Post</i> reports.</li>    <li>That follows an online petition from thousands of members of REI's co-op urging action, and REI is joined by Mountain Equipment Co-Op in cutting off sales of Vista products.</li>    <li>&ldquo;We believe that it is the job of companies that manufacture and sell guns and ammunition to work towards common sense solutions that prevent the type of violence that happened in Florida last month,&rdquo; REI says. \"In the last few days, we&rsquo;ve seen such action from companies like Dick&rsquo;s Sporting Goods and Walmart and we applaud their leadership. ... This morning we learned that Vista does not plan to make a public statement that outlines a clear plan of action.\"</li>    <li>\"Shooting sports\" make up 54% of Vista's external sales revenue, in brands including Savage Arms and Federal Premium Ammunition.</li><li>In its annual report, the company said \"we could find it difficult, expensive or even practically impossible to comply with\" firearm or ammo restrictions imposed by the government.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336126\" data-linked=\"Vista Outdoor -9% as co-ops halt brand sales over gun stance\" data-tweet=\"$VSTO - Vista Outdoor -9% as co-ops halt brand sales over gun stance https://seekingalpha.com/news/3336126-vista-outdoorminus-9-co-ops-halt-brand-sales-over-gun-stance?source=tweet\" data-url=\"https://seekingalpha.com/news/3336126-vista-outdoorminus-9-co-ops-halt-brand-sales-over-gun-stance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336125\" data-ts=\"1520001972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNA\" target=\"_blank\">VRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336125-verona-pharmas-rpl554-shows-treatment-effect-in-mid-stage-cf-study-shares-up-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verona Pharma&#39;s RPL554 shows treatment effect in mid-stage CF study; shares up 8%</a></h4><ul><li>A UK-based Phase 2a clinical trial evaluating Verona Pharma plc's (<a href='https://seekingalpha.com/symbol/VRNA' title='Verona Pharma plc'>VRNA</a> <font color='green'>+8%</font>) nebulized RPL554 in cystic fibrosis patients showed favorable pharmacokinetic and pharmacodynamic profiles and <a href=\"https://seekingalpha.com/pr/17090419-verona-pharma-reports-positive-top-line-data-phase-2a-trial-rpl554-cystic-fibrosis-patients\" target=\"_blank\">demonstrated </a>a statistically valid 6% improvement in lung function after a single dose.</li><li><a href=\"http://www.veronapharma.com/our-science/#our-science-pipeline-and-products\" target=\"_blank\">RPL554</a>, a dual inhibitor of the enzymes phosphodiesterase 3 and 4, is designed as an anti-inflammatory agent as well as a bronchodilator. It is also being developed to treat chronic obstructive pulmonary disease &#40;COPD&#41;.</li><li>Top-line data from a Phase 2b study in COPD should be available next quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336125\" data-linked=\"Verona Pharma&#39;s RPL554 shows treatment effect in mid-stage CF study; shares up 8%\" data-tweet=\"$VRNA - Verona Pharma&#39;s RPL554 shows treatment effect in mid-stage CF study; shares up 8% https://seekingalpha.com/news/3336125-verona-pharmas-rpl554-shows-treatment-effect-in-mid-stage-cf-study-shares-up-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3336125-verona-pharmas-rpl554-shows-treatment-effect-in-mid-stage-cf-study-shares-up-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336122\" data-ts=\"1520001555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336122-susquehanna-urges-buy-on-foot-lockers-sales-weakness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna urges Buy on Foot Locker&#39;s sales weakness</a></h4><ul>   <li>Foot Locker (NYSE:<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a>) is <font color='red'>12.1% lower</font> out of the open after continuing softness in comparable-store sales spurred a <a href=\"https://seekingalpha.com/news/3336060-foot-locker-8_5-percent-results-nike-ua-finnish-line-dinged\" target=\"_blank\">miss in its Q4 revenues</a>.</li>    <li>Susquehanna is sticking up for the stock despite being surprised by the sales drop, urging a Buy on the weakness.</li>    <li>Analyst Sam Poser is drawing confidence from results at Foot Locker U.S., Kid's Foot Locker, Champs, Runners and SideStep; most of the sales weakness came from the firm's international banners, Footaction and SIX02, he says. (h/t Bloomberg)</li>    <li>Inventory looks to be in good shape even if the mix isn't yet aligned, he says. His $70 price target implies 74% upside from today's lower price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336122\" data-linked=\"Susquehanna urges Buy on Foot Locker&#39;s sales weakness\" data-tweet=\"$FL - Susquehanna urges Buy on Foot Locker&#39;s sales weakness https://seekingalpha.com/news/3336122-susquehanna-urges-buy-on-foot-lockers-sales-weakness?source=tweet\" data-url=\"https://seekingalpha.com/news/3336122-susquehanna-urges-buy-on-foot-lockers-sales-weakness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336118\" data-ts=\"1520000695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336118-u-s-steel-downgraded-baml-seeing-limited-benefit-from-tariff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel downgraded at BAML, seeing limited benefit from tariff</a></h4><ul><li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color='red'>-2.5%</font> premarket after BofA&nbsp;Merrill Lynch <a href=\"https://twitter.com/thenotablecalls/status/969574072920281088\" target=\"_blank\">downgrades</a> shares to Neutral from Buy following the stock's recent run higher, as Pres. Trump's tariffs were largely expected.</li><li>BAML believes the tariff will have a limited benefit in 2018 due to previously contracted tonnage locking in lower prices, and the firm <a href=\"https://twitter.com/thenotablecalls/status/969574142327574529\" target=\"_blank\">expects steel prices to slide by 2019</a> because of likely WTO challenges and threats of trade retaliation, domestic capacity restarts and potential demand degradation as downstream products containing steel content could be imported.</li><li>J.P. Morgan's Michael Gambardella notes significant details around the tariffs, such as whether specific countries will be exempted, are <a href=\"https://twitter.com/thenotablecalls/status/969574211739103233\" target=\"_blank\">still lacking</a> so it is difficult to assess the ultimate impact on steel prices.</li><li>Among other tickers on watch: <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>, <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a>, <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a>, <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>, <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3336118\" data-linked=\"U.S. Steel downgraded at BAML, seeing limited benefit from tariff\" data-tweet=\"$X $X $AKS - U.S. Steel downgraded at BAML, seeing limited benefit from tariff https://seekingalpha.com/news/3336118-u-s-steel-downgraded-baml-seeing-limited-benefit-from-tariff?source=tweet\" data-url=\"https://seekingalpha.com/news/3336118-u-s-steel-downgraded-baml-seeing-limited-benefit-from-tariff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336116\" data-ts=\"1520000353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRRA\" target=\"_blank\">SRRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336116-sierra-oncology-prices-stock-offering-2_25-shares-down-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sierra Oncology prices stock offering at $2.25; shares down 13% premarket</a></h4><ul><li>Sierra Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a>) slumps&nbsp;<font color='red'>13%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17090698-sierra-oncology-announces-pricing-public-offering-common-stock\" target=\"_blank\">public offering </a>of 19M shares of common stock at $2.25 per share. Underwriters over-allotment is an additional 2.85M shares. Closing date is March 6.</li><li>Yesterday's close was $2.46.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336116\" data-linked=\"Sierra Oncology prices stock offering at $2.25; shares down 13% premarket\" data-tweet=\"$SRRA - Sierra Oncology prices stock offering at $2.25; shares down 13% premarket https://seekingalpha.com/news/3336116-sierra-oncology-prices-stock-offering-2_25-shares-down-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3336116-sierra-oncology-prices-stock-offering-2_25-shares-down-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336115\" data-ts=\"1520000294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFH\" target=\"_blank\">AFH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336115-premarket-losers-of-9-05-3-2-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (3/2/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings'>AFH</a> <font color='red'>-32%.</font></li><li><a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>&nbsp;<font color='red'>-16%</font>&nbsp;on negative analyst action.</li><li><a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336070-j-c-penney-beats-0_10-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a>&nbsp;<font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3335871-whitestone-reit-misses-0_03-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a>&nbsp;<font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3335872-sierra-oncology-readies-stock-offering-shares-8-percent-hours\" target=\"_blank\">announcing</a> public offering of common Stock.</li><li><a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3335867-american-outdoor-brands-beats-0_01-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3335832-omeros-misses-0_20-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336019-jd-com-misses-0_02-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3335840-pure-storage-beats-0_06-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336040-foot-locker-beats-0_01-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3335856-nordstrom-misses-0_04-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3336115\" data-linked=\"Premarket Losers as of 9:05 am (3/2/2018)\" data-tweet=\"$AFH $AFH $OPK - Premarket Losers as of 9:05 am (3/2/2018) https://seekingalpha.com/news/3336115-premarket-losers-of-9-05-3-2-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336115-premarket-losers-of-9-05-3-2-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336114\" data-ts=\"1520000062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336114-premarket-gainers-of-9-05-03-02-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (03/02/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a>&nbsp;<font color='green'>+44%</font>&nbsp;on issuance of new U.S. patent covering M207 as an acute treatment for <a href=\"https://seekingalpha.com/pr/17090616-zosano-pharma-announces-issuance-new-u-s-patent-covering-m207-acute-treatment-migraine\" target=\"_blank\">migraine</a>.</li>     <li>GPS&nbsp;<font color='green'>+7%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3335884-gap-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li>     <li>FNJN&nbsp;<font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3335829-finjan-symantec-settle-disputes-finjan-plus-10_5-percent\" target=\"_blank\">settling</a> all disputes.</li>     <li>SGYP&nbsp;<font color='green'>+5%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3335897-synergy-pharma-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336114\" data-linked=\"Premarket Gainers as of 9:05 am (03/02/2018)\" data-tweet=\"$ZSAN - Premarket Gainers as of 9:05 am (03/02/2018) https://seekingalpha.com/news/3336114-premarket-gainers-of-9-05-03-02-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336114-premarket-gainers-of-9-05-03-02-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336113\" data-ts=\"1519999998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336113-insys-launches-late-stage-study-of-cbd-in-infantile-spasms-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INSYS launches late-stage study of CBD in infantile spasms; shares up 1% premarket</a></h4><ul><li>INSYS Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a>) <a href=\"https://seekingalpha.com/pr/17090625-insys-therapeutics-initiates-phase-3-clinical-trial-cannabidiol-cbd-oral-solution-treatment\" target=\"_blank\">initiates </a>a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03421496?spons=insys+therapeutics&amp;phase=2&amp;rank=1\" target=\"_blank\">Phase 3 clinical trial</a> evaluating cannabidiol &#40;CBD&#41; oral solution in young children with a rare type of epilepsy called infantile spasms.</li><li>The primary endpoint of the 190-subject study is the proportion of complete responders versus placebo. According to ClinicalTrials.gov, the estimated primary completion date is October.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336113\" data-linked=\"INSYS launches late-stage study of CBD in infantile spasms; shares up 1% premarket\" data-tweet=\"$INSY $INSYQ - INSYS launches late-stage study of CBD in infantile spasms; shares up 1% premarket https://seekingalpha.com/news/3336113-insys-launches-late-stage-study-of-cbd-in-infantile-spasms-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3336113-insys-launches-late-stage-study-of-cbd-in-infantile-spasms-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336109\" data-ts=\"1519999170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BW\" target=\"_blank\">BW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336109-babcock-wilcoxminus-18-after-posting-larger-expected-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Babcock &amp; Wilcox -18% after posting larger than expected Q4 loss</a></h4><ul>     <li>Babcock &amp;&nbsp;Wilcox (NYSE:<a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a>)&nbsp;<font color='red'>-17.9%</font> premarket after its <a href=\"https://seekingalpha.com/news/3335936-babcock-and-wilcox-enterprises-misses-0_89-misses-revenue\" target=\"_blank\">Q4 loss</a> of $0.95/share comes in far below analyst consensus of a $0.06/share loss, and revenues also missed estimates despite rising 7.4% Y/Y.</li>     <li>BW says Q4 revenues for the Power segment fell 5% Y/Y to $209M, mainly due to lower activities on new-build utility and environmental projects and lower sales of industrial steam generation systems.</li>     <li>BW provides FY 2018 adjusted EBITDA guidance of $75M-$95M, and sees FY 2018 sales $1.5B-$1.7B vs. $1.56B consensus.</li>     <li>The company also says it entered into another amendment to its first-lien revolving credit facility and received a commitment letter to backstop a $182M rights offering of common stock, priced at $3/share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336109\" data-linked=\"Babcock &amp; Wilcox -18% after posting larger than expected Q4 loss\" data-tweet=\"$BW - Babcock &amp; Wilcox -18% after posting larger than expected Q4 loss https://seekingalpha.com/news/3336109-babcock-wilcoxminus-18-after-posting-larger-expected-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3336109-babcock-wilcoxminus-18-after-posting-larger-expected-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336106\" data-ts=\"1519998945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMW\" target=\"_blank\">VMW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336106-analysts-adjust-vmware-targets-after-earnings-potential-dell-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts adjust VMware targets after earnings, potential Dell merger</a></h4><ul><li>        Stifel downgrades VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) from Buy to Hold and lowers the price target from $152 to $135, a 9% upside to yesterday&rsquo;s close.</li><li>                  Stifel cites ongoing overhang from Dell&rsquo;s (DVMT) potential reverse merger.    </li><li>               Firm says VMware delivered a solid quarter yesterday and shares trade at 10.6x CY19E EV/FCF, but doesn&rsquo;t expect significant multiple expansions while the overhang exists and considers Red Hat (NYSE:<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a>) a better hybrid cloud play.&nbsp;</li><li>               More action: BMO lowers its VMware target from $142 to $138 (12% upside) on the potential merger.&nbsp;</li><li>               And more: Mizuho raises its VMware target from $110 to $125, citing upsides in the earnings results and a seemingly healthy demand environment. But the company stays on the sidelines, considering the stock fully valued at current levels.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               VMware shares are&nbsp;<font color='red'>down 3.4%</font>&nbsp;premarket to $119.50.&nbsp;</li><li>               Dell shares are&nbsp;<font color='red'>down 0.5%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335805-cnbc-dell-vmware-reverse-merger-decision-come-soon\" target=\"_blank\">CNBC: Dell, VMware reverse merger decision could come soon</a> (March 1)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335902-vmware-beats-0_06-beats-revenue\" target=\"_blank\">VMware beats by $0.06, beats on revenue</a> (March 1)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335939-vmware-reports-q4-beats-20-percent-license-revenue-growth\" target=\"_blank\">VMware reports Q4 beats, 20% license revenue growth</a> (March 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336106\" data-linked=\"Analysts adjust VMware targets after earnings, potential Dell merger\" data-tweet=\"$VMW $VMW $DELL - Analysts adjust VMware targets after earnings, potential Dell merger https://seekingalpha.com/news/3336106-analysts-adjust-vmware-targets-after-earnings-potential-dell-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3336106-analysts-adjust-vmware-targets-after-earnings-potential-dell-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336104\" data-ts=\"1519998820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336104-sizable-losses-in-store-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sizable losses in store at the open</a></h4><ul><li>The big losing streak for markets is set to continue at least to open the day, with Dow (NYSEARCA:<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>) and Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='PowerShares QQQ Trust ETF'>QQQ</a>) futures each&nbsp;<font color='red'>down more than 1%</font>, and S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) futures&nbsp;<font color='red'>off 0.75%</font>.</li><li>Tariffs, rate fears, and equity markets that have been going only upwards for far too long - pick your excuse.</li><li>Europe's&nbsp;<font color='red'>down 1.6%</font>&nbsp;at midday.</li><li>The 10-year U.S. Treasury yield is up three basis points 2.838%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336104\" data-linked=\"Sizable losses in store at the open\" data-tweet=\"$DIA $QQQ $SPY - Sizable losses in store at the open https://seekingalpha.com/news/3336104-sizable-losses-in-store-open?source=tweet\" data-url=\"https://seekingalpha.com/news/3336104-sizable-losses-in-store-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336101\" data-ts=\"1519998392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336101-zosano-pharma-issues-new-u-s-patent-covering-m207-acute-treatment-for-migraine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano Pharma issues new U.S. patent covering M207 as an acute treatment for migraine</a></h4><ul><li>Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a>) <a href=\"https://seekingalpha.com/pr/17090616-zosano-pharma-announces-issuance-new-u-s-patent-covering-m207-acute-treatment-migraine\" target=\"_blank\">announces</a> that its previous patent application titled &ldquo;Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines&rdquo; has resulted in the issuance of a U.S. patent 9,918,932.</li><li>The newly issued patent contains claims generated from formulation, preclinical and clinical studies, and highlights the unique aspects of the Zosano technologies and their applicability for treatment of migraine.</li><li>Shares are up&nbsp;<font color='green'>65%</font>&nbsp;premarket on light volume.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3336101\" data-linked=\"Zosano Pharma issues new U.S. patent covering M207 as an acute treatment for migraine\" data-tweet=\"$ZSAN - Zosano Pharma issues new U.S. patent covering M207 as an acute treatment for migraine https://seekingalpha.com/news/3336101-zosano-pharma-issues-new-u-s-patent-covering-m207-acute-treatment-for-migraine?source=tweet\" data-url=\"https://seekingalpha.com/news/3336101-zosano-pharma-issues-new-u-s-patent-covering-m207-acute-treatment-for-migraine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336097\" data-ts=\"1519997765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNOA\" target=\"_blank\">SNOA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336097-sonoma-pharmaceuticals-prices-common-stock-offering-3_50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonoma Pharmaceuticals prices common stock offering at $3.50</a></h4><ul> <li>Sonoma Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNOA' title='Sonoma Pharmaceuticals, Inc.'>SNOA</a>) <a href=\"https://seekingalpha.com/pr/17090575-sonoma-pharmaceuticals-announces-pricing-5-million-public-offering-common-stock\" target=\"_blank\">prices</a> public offering of up to 1.4M shares of common stock at $3.50 per share for gross proceeds of ~$5M.</li>   <li>Closing date is March 6.</li><li>Shares are up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3336097\" data-linked=\"Sonoma Pharmaceuticals prices common stock offering at $3.50\" data-tweet=\"$SNOA - Sonoma Pharmaceuticals prices common stock offering at $3.50 https://seekingalpha.com/news/3336097-sonoma-pharmaceuticals-prices-common-stock-offering-3_50?source=tweet\" data-url=\"https://seekingalpha.com/news/3336097-sonoma-pharmaceuticals-prices-common-stock-offering-3_50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336094\" data-ts=\"1519997218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336094-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a>) initiated with Outperform rating and $16 (208% upside) price target at Oppenheimer.</li><li>Medical Transcription Billing (NASDAQ:<a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a>) initiated with Buy rating and $5 (37% upside) at H.C. Wainwright.</li><li>RTI Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/RTIX' title='RTI Surgical, Inc.'>RTIX</a>) upgraded to Buy at Craig Hallum.</li><li>Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy'>DPLO</a>) upgraded to Buy at Deutsche Bank.</li><li>Opko Health (NYSEMKT:<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>) downgraded to Underweight at JPMorgan after Q4 miss. Shares down&nbsp;<font color='red'>17%</font>&nbsp;premarket on increased volume.</li><li>Cross Country Healthcare (NASDAQ:<a href='https://seekingalpha.com/symbol/CCRN' title='Cross Country Healthcare, Inc.'>CCRN</a>) downgraded to Neutral with an $11 (3% upside) price target at Cantor Fitzgerald.</li><li>Paratek Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a>) downgraded to Outperform from Strong Buy at Raymond James. Price target is $34 (166% upside).</li></ul><div class=\"tiny-share-widget\" data-id=\"3336094\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$CNAT $CNAT $MTBC - Premarket analyst action - healthcare https://seekingalpha.com/news/3336094-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3336094-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336093\" data-ts=\"1519997161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336093-j-c-penney-down-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney down post Q4 results</a></h4><ul><li>J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) reports comparable sales increased 2.6% in <a href=\"http://ir.jcpenney.com/phoenix.zhtml?c=70528&amp;p=irol-newsArticle&amp;ID=2335882\" target=\"_blank\">Q4</a>.</li><li>Jewelry, Home, Sephora, Footwear and Handbags and Salon were the top performing divisions during the quarter.</li><li>Gross margin rate improved 50 bps to 33.6%.</li><li>SG&amp;A expense rate flat Y/Y at 23.4%.</li><li>Adjusted EBITDA dropped 8% to $413M.</li><li>Merchandise inventory fell 3.2% to $2.76B.</li><li>The company reduced debt by $600M and generated over $200M of free cash flow.</li><li><strong>FY2018 Guidance</strong>: Comparable store sales: 0.0% to +2%; Adjusted EPS: $0.05 to $0.25.</li><li>Marvin R. Ellison, chairman and chief executive officer said,&nbsp;\"In 2018, we will intensify our market share efforts in Appliances, Mattresses and Furniture, while continuing to take steps to modernize our apparel assortment and omni-channel.&nbsp; Our strategy and plan is clear and consistent, and we remain focused on two critical factors - to operate the business for growth and deliver profitable earnings.&nbsp; I would like to thank our nearly 100,000 associates around our company for their hard work and more importantly, for their commitment to JCPenney.\"</li><li>JCP&nbsp;<font color='red'>-8.16%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336093\" data-linked=\"J.C. Penney down post Q4 results\" data-tweet=\"$JCP - J.C. Penney down post Q4 results https://seekingalpha.com/news/3336093-j-c-penney-down-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3336093-j-c-penney-down-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336090\" data-ts=\"1519996793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RETA\" target=\"_blank\">RETA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336090-reata-pharmas-omaveloxolone-flunks-mid-stage-study-in-mitochondrial-myopathies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reata Pharma&#39;s omaveloxolone flunks mid-stage study in mitochondrial myopathies</a></h4><ul><li>Reata Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a>) omaveloxolone <a href=\"https://seekingalpha.com/pr/17090272-reata-announces-top-line-data-dose-escalation-cohorts-phase-2-motor-study-omaveloxolone\" target=\"_blank\">failed to sufficiently separate</a> from placebo in a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02255422?term=reata+pharmaceuticals&amp;rank=11\" target=\"_blank\">MOTOR</a>, assessing omaveloxolone (RTA 408) in patients with mitochondrial myopathies.</li><li>Patients in the treatment group did not perform better than those treated with placebo during exercise testing (peak work), the primary endpoint, or in the 6-minute walk test, the secondary endpoint.</li><li>Mitochondrial myopathies are a group of disorders that result from the dysfunction of mitochondria, organelles in most cells that produce 90% of the energy needed to sustain life. Affected people have difficulty performing daily activities due to low energy levels.</li><li><a href=\"https://reatapharma.com/our-science/nrf2-activators/\" target=\"_blank\">Nrf2 is a transcription factor</a> that promotes normal mitochondrial function. Omaveloxolone is a Nrf2 activator that restores mitochondrial production of an enzyme called ATP (adenosine triphosphate) that plays an essential role in energy production. It also increases the production of antioxidants which reduces oxidative stress and inflammatory signaling, the underlying causes of a range of diseases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336090\" data-linked=\"Reata Pharma&#39;s omaveloxolone flunks mid-stage study in mitochondrial myopathies\" data-tweet=\"$RETA - Reata Pharma&#39;s omaveloxolone flunks mid-stage study in mitochondrial myopathies https://seekingalpha.com/news/3336090-reata-pharmas-omaveloxolone-flunks-mid-stage-study-in-mitochondrial-myopathies?source=tweet\" data-url=\"https://seekingalpha.com/news/3336090-reata-pharmas-omaveloxolone-flunks-mid-stage-study-in-mitochondrial-myopathies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336089\" data-ts=\"1519996603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTG\" target=\"_blank\">PSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336089-susquehanna-downgrades-pure-storage-maintains-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna downgrades Pure Storage, maintains target</a></h4><ul><li>        Susquehanna <a href=\"https://www.streetinsider.com/Analyst+Comments/Susquehanna+Downgrades+Pure+Storage+%28PSTG%29+to+Neutral/13894109.html\" target=\"_blank\">downgrades</a> Pure Storage (NYSE:<a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a>) from Positive to Neutral with a price target of $22.</li><li>               Analyst Mehdi Hosseini attributes the downgrade to the fact that the firm&rsquo;s $22 target represents only about a 5% upside from current levels and the firm lacks visibility to merit a target increase.&nbsp;</li><li>               Pure Storage shares are&nbsp;<font color='red'>down 8.2%</font>&nbsp;premarket to $20 following yesterday&rsquo;s aftermarket earnings report. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335961-pure-storage-minus-6_8-percent-q4-beats-line-guidance\" target=\"_blank\">Pure Storage -6.8% after Q4 beats with in-line guidance</a> (March 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336089\" data-linked=\"Susquehanna downgrades Pure Storage, maintains target\" data-tweet=\"$PSTG - Susquehanna downgrades Pure Storage, maintains target https://seekingalpha.com/news/3336089-susquehanna-downgrades-pure-storage-maintains-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3336089-susquehanna-downgrades-pure-storage-maintains-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336086\" data-ts=\"1519996343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336086-mcdonalds-down-2_7-on-dour-rbc-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDonald&#39;s down 2.7% on dour RBC note</a></h4><ul><li>A combination of the macro (\"deteriorating industry conditions\") and the micro (\"disappointing\" start to the new $1 $2 $3 value menu) has RBC's David Palmer <a href=\"https://www.marketwatch.com/story/mcdonalds-price-target-slashed-after-slow-start-to-1-2-3-menu-2018-03-02\" target=\"_blank\">cutting his </a>same-store sales growth forecast for Q1 to 1% from 3.5%, and his price target to $170 from $190.</li><li>\"Our sense is that the $1 $2 $3 platform stole attention from local marketing, particularly at breakfast, which likely slowed as a consequence,\" say Palmer and team. They maintain an Outperform rating on the stock.</li><li><a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a>&nbsp;<font color='red'>-2.7%</font>&nbsp;premarket to $151.50</li></ul><div class=\"tiny-share-widget\" data-id=\"3336086\" data-linked=\"McDonald&#39;s down 2.7% on dour RBC note\" data-tweet=\"$MCD - McDonald&#39;s down 2.7% on dour RBC note https://seekingalpha.com/news/3336086-mcdonalds-down-2_7-on-dour-rbc-note?source=tweet\" data-url=\"https://seekingalpha.com/news/3336086-mcdonalds-down-2_7-on-dour-rbc-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336083\" data-ts=\"1519996057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUN\" target=\"_blank\">RUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336083-sunrun-initiated-buy-44-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunrun initiated at Buy, 44% upside</a></h4><ul><li>        ROTH Capital <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Roth+Capital+Starts+Sunrun+%28RUN%29+at+Buy/13893479.html\" target=\"_blank\">initiates</a> Sunrun (NASDAQ:<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a>) with a Buy rating and a $10 price target</li><li>        The new target represents a 44% upside to yesterday&rsquo;s close.</li><li>               Sunrun shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;premarket to $7.04 with a 52-week range of $4.21 to $7.78.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336083\" data-linked=\"Sunrun initiated at Buy, 44% upside\" data-tweet=\"$RUN - Sunrun initiated at Buy, 44% upside https://seekingalpha.com/news/3336083-sunrun-initiated-buy-44-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3336083-sunrun-initiated-buy-44-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336071\" data-ts=\"1519995369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336071-rough-session-for-nikkei-and-yen-surges-after-kuroda-remarks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for Nikkei, and yen surges after Kuroda remarks</a></h4><ul><li>The Bank of Japan Governor for the first time overnight <a href=\"https://www.bloomberg.com/news/articles/2018-03-02/kuroda-says-boj-will-be-thinking-about-exit-in-around-2019\" target=\"_blank\">began talking about an</a> exit from the central bank's extraordinary stimulus program. That doesn't mean rate hikes are coming next month. Instead Kuroda pointed to 2019 as a time for the BOJ to begin thinking about a change.</li><li>Kuroda says he and the policy board are expecting inflation to reach the 2% target sometime next year, so it&nbsp; makes sense to consider curtailing stimulus.</li><li>The Nikkei&nbsp;<font color='red'>fell 2.5%</font>, and the yen is&nbsp;<font color='green'>up 1%</font>&nbsp;vs. the dollar.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/DXJ' title='WisdomTree Japan Hedged Equity ETF'>DXJ</a>, <a href='https://seekingalpha.com/symbol/EWJ' title='iShares MSCI Japan ETF'>EWJ</a>, <a href='https://seekingalpha.com/symbol/FXY' title='Guggenheim CurrencyShares Japanese Yen Trust ETF'>FXY</a>, <a href='https://seekingalpha.com/symbol/YCS' title='ProShares UltraShort Yen ETF'>YCS</a>, <a href='https://seekingalpha.com/symbol/DBJP' title='Deutsche X-trackers MSCI Japan Hedged Equity ETF'>DBJP</a>, <a href='https://seekingalpha.com/symbol/JYN' title='iPath JPY/USD Exchange Rate ETN'>JYN</a>, <a href='https://seekingalpha.com/symbol/JPNL' title='Direxion Daily Japan Bull 3x Shares ETF'>JPNL</a>, <a href='https://seekingalpha.com/symbol/HEWJ' title='iShares Currency Hedged MSCI Japan ETF'>HEWJ</a>, <a href='https://seekingalpha.com/symbol/JEQ' title='Japan Equity Fund'>JEQ</a>, <a href='https://seekingalpha.com/symbol/YCL' title='ProShares Ultra Yen ETF'>YCL</a>, <a href='https://seekingalpha.com/symbol/EWV' title='ProShares UltraShort MSCI Japan ETF'>EWV</a>, <a href='https://seekingalpha.com/symbol/EZJ' title='ProShares Ultra MSCI Japan ETF'>EZJ</a>, <a href='https://seekingalpha.com/symbol/JPXN' title='iShares JPX-Nikkei 400 ETF'>JPXN</a>, <a href='https://seekingalpha.com/symbol/JPN' title='Deutsche X-trackers Japan JPX-Nikkei 400 Equity ETF'>JPN</a>, <a href='https://seekingalpha.com/symbol/FJP' title='First Trust Japan AlphaDEX ETF'>FJP</a>, <a href='https://seekingalpha.com/symbol/HJPX' title='iShares Currency Hedged JPX-Nikkei 400 ETF'>HJPX</a>, <a href='https://seekingalpha.com/symbol/DEWJ' title='iShares Adaptive Currency Hedged MSCI Japan ETF'>DEWJ</a>, <a href='https://seekingalpha.com/symbol/GSJY' title='Goldman Sachs ActiveBeta Japan Equity ETF'>GSJY</a>, <a href='https://seekingalpha.com/symbol/HFXJ' title='IQ 50 Percent Hedged FTSE Japan ETF'>HFXJ</a>, <a href='https://seekingalpha.com/symbol/JPNH' title='Deutsche X-trackers Japan JPX-Nikkei 400 Hedged Equity ETF'>JPNH</a>, <a href='https://seekingalpha.com/symbol/DJPY' title='VelocityShares Daily 4X Long USD vs. JPY ETN'>DJPY</a>, <a href='https://seekingalpha.com/symbol/FLJH' title='Franklin FTSE Japan Hedged ETF'>FLJH</a>, <a href='https://seekingalpha.com/symbol/FLJP' title='Franklin FTSE Japan ETF'>FLJP</a>, <a href='https://seekingalpha.com/symbol/UJPY' title='VelocityShares Daily 4X Long JPY vs. USD ETN'>UJPY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3336071\" data-linked=\"Rough session for Nikkei, and yen surges after Kuroda remarks\" data-tweet=\"$DXJ $EWJ $FXY - Rough session for Nikkei, and yen surges after Kuroda remarks https://seekingalpha.com/news/3336071-rough-session-for-nikkei-and-yen-surges-after-kuroda-remarks?source=tweet\" data-url=\"https://seekingalpha.com/news/3336071-rough-session-for-nikkei-and-yen-surges-after-kuroda-remarks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336067\" data-ts=\"1519994822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336067-jd-comminus-6_6-on-q4-misses-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com -6.6% on Q4 misses, in-line guidance</a></h4><ul><li>        JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a>)&nbsp;<font color='red'>plunges 6.6%</font>&nbsp;premarket on Q4 results that missed revenue and EPS estimates.</li><li>                  In-line Q1 guidance has revenue from $15.4B to $15.8B (consensus: $15.7B).   </li><li>               <a href=\"https://seekingalpha.com/pr/17090442-jd-com-announces-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a>&nbsp;</li><li>               The earnings call started at 7:30 AM ET with a live and archived webcast available <a href=\"http://ir.jd.com/phoenix.zhtml?c=253315&amp;p=irol-IRHome\" target=\"_blank\">here</a>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336019-jd-com-misses-0_02-misses-revenue\" target=\"_blank\">JD.com misses by $0.02, misses on revenue</a> (March 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336067\" data-linked=\"JD.com -6.6% on Q4 misses, in-line guidance\" data-tweet=\"$JD - JD.com -6.6% on Q4 misses, in-line guidance https://seekingalpha.com/news/3336067-jd-comminus-6_6-on-q4-misses-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3336067-jd-comminus-6_6-on-q4-misses-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336060\" data-ts=\"1519993853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336060-foot-locker-down-8_5-after-results-nike-ua-finnish-line-dinged-too\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foot Locker down 8.5% after results; Nike, UA, Finnish Line dinged too</a></h4><ul><li>Foot Locker's (NYSE:<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a>) FQ4 (ended Feb. 3) EPS of $1.26 topped estimates by a penny, but comp-store sales fell a worse-than-hoped 3.7% Y/Y.</li><li>The 2018 outlook calls for flat-to-slightly up comp-store sales, and an improvement in gross margins (which fell during 2017). Said forecast is dependent on a strong H2, as 2017's softness is seen continuing through the first half of this year.</li><li>The <a href=\"http://www.footlocker-inc.com\" target=\"_blank\">conference call </a>is set for 9 ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336040-foot-locker-beats-0_01-misses-revenue\" target=\"_blank\">Foot Locker beats by $0.01, misses on revenue</a> (March 2)</li><li>FL&nbsp;<font color='red'>-8.5%</font>&nbsp;premarket. Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>)&nbsp;<font color='red'>-2.1%</font>, Under Armour (NYSE:<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>)&nbsp;<font color='red'>-1.4</font>%, Finish Line (NASDAQ:<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a>)&nbsp;<font color='red'>-0.2%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3336060\" data-linked=\"Foot Locker down 8.5% after results; Nike, UA, Finnish Line dinged too\" data-tweet=\"$FL $FL $NKE - Foot Locker down 8.5% after results; Nike, UA, Finnish Line dinged too https://seekingalpha.com/news/3336060-foot-locker-down-8_5-after-results-nike-ua-finnish-line-dinged-too?source=tweet\" data-url=\"https://seekingalpha.com/news/3336060-foot-locker-down-8_5-after-results-nike-ua-finnish-line-dinged-too\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336057\" data-ts=\"1519993401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPE\" target=\"_blank\">HPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336057-hewlett-packard-enterprise-initiated-14-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hewlett Packard Enterprise initiated at 14% upside</a></h4><ul><li>        JPMorgan initiates Hewlett Packard Enterprise (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a>) with a Neutral rating and a $21 price target.</li><li>               Source: Briefing.com.&nbsp;</li><li>               The new target represents a 14% upside to yesterday&rsquo;s close.&nbsp;</li><li>               HPE shares are&nbsp;<font color='green'>up &nbsp;0.5%</font>&nbsp;premarket to $18.41 with a 52-week range of $12.70 to $19.13.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336057\" data-linked=\"Hewlett Packard Enterprise initiated at 14% upside\" data-tweet=\"$HPE - Hewlett Packard Enterprise initiated at 14% upside https://seekingalpha.com/news/3336057-hewlett-packard-enterprise-initiated-14-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3336057-hewlett-packard-enterprise-initiated-14-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336056\" data-ts=\"1519993383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSR\" target=\"_blank\">WSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336056-whitestone-reit-down-10-after-miss-soft-guidance-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whitestone REIT down 10% after miss, soft guidance, downgrade</a></h4><ul><li>Whitestone (NYSEMKT:<a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a>) last night&nbsp;<a href=\"https://seekingalpha.com/news/3335896-whitestone-reit-misses-sees-decline-ffo-2018\" target=\"_blank\">reported a</a> sizable earnings miss, and forecast another decline in core FFO this year.</li><li>SunTrust's Ki Bin Kim downgrades to Sell from Hold, and cuts the price target to $10 from $12.50.</li><li>Shares&nbsp;<font color='red'>down 10.4%</font>&nbsp;premarket to $11.12.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336056\" data-linked=\"Whitestone REIT down 10% after miss, soft guidance, downgrade\" data-tweet=\"$WSR - Whitestone REIT down 10% after miss, soft guidance, downgrade https://seekingalpha.com/news/3336056-whitestone-reit-down-10-after-miss-soft-guidance-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3336056-whitestone-reit-down-10-after-miss-soft-guidance-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336052\" data-ts=\"1519993030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYTU\" target=\"_blank\">AYTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336052-aytu-bio-prices-equity-offering-shares-down-24-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aytu Bio prices equity offering; shares down 24% premarket</a></h4><ul><li>Aytu BioScience (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>) is down&nbsp;<font color='red'>24%</font>&nbsp;premarket on light volume in response to the <a href=\"https://seekingalpha.com/pr/17090362-aytu-bioscience-announces-pricing-12000-000-public-offering\" target=\"_blank\">pricing </a>of its $12M equity offering consisting of Class A and Class B Units.</li><li>Class A Units consist of an aggregate of 19.52M shares of common stock and warrants to purchase 19.52M shares of common, each Unit priced at $0.45.</li><li>Class B Units consist of 3,216 shares of Series B Convertible Preferred Stock valued at $1,000 per share, convertible into an aggregate of 7,146,667 common shares and warrants to purchase up to 7,146,667 common shares. Each Class B Unit is priced at $1,000.</li><li>The warrants have a term of five years and are exercisable at $0.54 per common share.</li><li>Closing date is March 6.</li><li>Yesterday's close was $0.56.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336052\" data-linked=\"Aytu Bio prices equity offering; shares down 24% premarket\" data-tweet=\"$AYTU - Aytu Bio prices equity offering; shares down 24% premarket https://seekingalpha.com/news/3336052-aytu-bio-prices-equity-offering-shares-down-24-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3336052-aytu-bio-prices-equity-offering-shares-down-24-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336045\" data-ts=\"1519991896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336045-biogen-and-abbvie-withdraw-ms-med-zinbryta-from-market-after-serious-side-effects-reported\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen and AbbVie withdraw MS med Zinbryta from the market after serious side effects reported; Biogen down 2% premarket</a></h4><ul><li>Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) and collaboration partner AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) <a href=\"https://seekingalpha.com/pr/17090440-biogen-abbvie-announce-voluntary-worldwide-withdrawal-marketing-authorizations-zinbryta\" target=\"_blank\">announce </a>the withdrawal of relapsing multiple sclerosis drug ZINBRYTA (daclizumab) from global markets following reports of inflammatory encephalitis and meningoencephalitis.</li><li>ZINBRYTA is currently approved for sale in the EU, U.S., Switzerland, Canada and Australia.</li><li>Biogen is down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336045\" data-linked=\"Biogen and AbbVie withdraw MS med Zinbryta from the market after serious side effects reported; Biogen down 2% premarket\" data-tweet=\"$BIIB $BIIB $ABBV - Biogen and AbbVie withdraw MS med Zinbryta from the market after serious side effects reported; Biogen down 2% premarket https://seekingalpha.com/news/3336045-biogen-and-abbvie-withdraw-ms-med-zinbryta-from-market-after-serious-side-effects-reported?source=tweet\" data-url=\"https://seekingalpha.com/news/3336045-biogen-and-abbvie-withdraw-ms-med-zinbryta-from-market-after-serious-side-effects-reported\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336043\" data-ts=\"1519991432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336043-arcelormittal-nippon-steel-form-jv-to-bid-for-indias-essar-steel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal, Nippon Steel form JV to bid for India&#39;s Essar Steel</a></h4><ul>     <li>ArcelorMittal (NYSE:<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>) says it is <a href=\"https://www.reuters.com/article/us-essar-steel-m-a-bids/arcelormittal-teams-up-with-nippon-steel-to-bid-for-indias-essar-steel-idUSKCN1GE0MN\" target=\"_blank\">forming a joint venture</a> with Japan&rsquo;s Nippon Steel &amp; Sumitomo Metal (<a href='https://seekingalpha.com/symbol/NISTF' title='Nippon Steel & Sumitomo Metal Corp'>OTCPK:NISTF</a>) to bid for bankrupt steelmaker Essar Steel India, seeking a deal that could total at least $6B.</li>     <li>The venture is MT&rsquo;s latest attempt to crack the fast-growing Indian steel market, where it has struggled for a decade to make inroads because of bureaucratic delays.</li>     <li>Separately, MT says it is <a href=\"https://www.reuters.com/article/usa-trade-arcelormittal/arcelormittal-says-assessing-impact-of-u-s-steel-tariffs-idUSS8N1JX01K\" target=\"_blank\">assessing the potential impact</a> of planned U.S. tariffs on steel imports; the company, which has sizeable operations in both Europe and the U.S., repeatedly has complained about cheap imports from China and other countries hurting its business.</li>     <li>MT <font color='red'>-2.4%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336043\" data-linked=\"ArcelorMittal, Nippon Steel form JV to bid for India&#39;s Essar Steel\" data-tweet=\"$MT $MT $NISTF - ArcelorMittal, Nippon Steel form JV to bid for India&#39;s Essar Steel https://seekingalpha.com/news/3336043-arcelormittal-nippon-steel-form-jv-to-bid-for-indias-essar-steel?source=tweet\" data-url=\"https://seekingalpha.com/news/3336043-arcelormittal-nippon-steel-form-jv-to-bid-for-indias-essar-steel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336041\" data-ts=\"1519991307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGO\" target=\"_blank\">PRGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336041-perrigo-q4-top-line-off-4-non-gaap-earnings-up-1-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perrigo Q4 top line off 4%; non-GAAP earnings up 1%; shares up 1% premarket</a></h4><ul><li>Perrigo (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a>) <a href=\"https://seekingalpha.com/pr/17090261-perrigo-company-plc-reports-fourth-quarter-and-calendar-year-2017-financial-results\" target=\"_blank\">Q4 results</a> ($M): Net Sales: 1,283 (-3.6%).</li><li>Net income: 73 (+105.4%); non-GAAP net income: 180 (+1.1%); EPS: 0.52 (+105.5%); non-GAAP EPS: 1.28 (+3.2%).</li><li>Cash flow ops (full-year): 698.9 (+6.7%).</li><li><strong>2018 guidance</strong>: Net sales: $5.0B - 5.1B; EPS: $2.24 - 2.64; non-GAAP EPS: $5.05 - 5.45.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336041\" data-linked=\"Perrigo Q4 top line off 4%; non-GAAP earnings up 1%; shares up 1% premarket\" data-tweet=\"$PRGO - Perrigo Q4 top line off 4%; non-GAAP earnings up 1%; shares up 1% premarket https://seekingalpha.com/news/3336041-perrigo-q4-top-line-off-4-non-gaap-earnings-up-1-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3336041-perrigo-q4-top-line-off-4-non-gaap-earnings-up-1-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:48 AM </div></div></li>","count":68,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}